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 Chronic biofilm-related infections caused by the human pathogen 
Staphylococcus aureus often lead to significant increases in morbidity and mortality in 
both hospital- and community-associated settings. Typically, S. aureus biofilm 
development occurs in three stages: 1) attachment, 2) tower maturation, and 3) 
dispersal. Here, utilizing BioFlux1000 time-lapse microscopy we have expanded upon 
these fundamental stages of biofilm development and also unveiled and characterized 
two additional stages (multiplication and exodus).  
 The attachment and multiplication stages were shown to be protease sensitive 
but independent of most cell surface-associated proteins. Following multiplication, an 
exodus of the biofilm population that followed the transition of the biofilm to DNase I 
sensitivity was demonstrated. Furthermore, disruption of the gene encoding 
staphylococcal nuclease (nuc) abrogated this exodus event, causing hyper-proliferation 
of the biofilm and disrupting tower development. Prior to exodus, cells carrying a 
Pnuc::gfp promoter fusion demonstrated Sae-dependent expression, but only in a 
subpopulation of cells. Additionally, we also determined that other Sae-regulated genes 
demonstrated unique Sae-dependent stochastic expression patterns. Collectively, these 
results suggest the presence of a Sae-controlled nuclease-mediated exodus of a biofilm 
subpopulation that is required for tower development as well as controlling the stochastic 
expression of Sae-regulated factors.  
 The cidABC and lrgAB operons have previously been shown to play specific 
roles in controlled cell death and release of extracellular DNA (eDNA) during biofilm 
maturation.  Although the exact mechanisms controlling the cid and lrg operons have yet 
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to be completely elucidated, the expression of the operons is dependent on altered 
metabolic cues as a result of overflow metabolism. We hypothesized that the differential 
expression of the cid and lrg operons within a biofilm is a function of the metabolic 
heterogeneity found within different biofilm microenvironments. Time-lapse 
epifluorescent images indicate that expression of these operons is specific to distinct 
regions of a growing biofilm.  Additionally, these results revealed the existence of 
different tower types, possibly reflecting their different functional roles in development.  
Altogether, nuclease-mediated eDNA degradation modulates the biofilm to produce two 
distinct towers that there are both spatially and temporally different between compared 
to the rest of the biofilm.   
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CHAPTER I: 
INTRODUCTION - LITERATURE REVIEW 
Staphylococcus aureus  
Epidemiology 
 The highly virulent human pathogen, Staphylococcus aureus, is a facultative 
Gram-positive bacterium that can colonize several places on the human body including 
skin, throat, axilla, perirectal, groin and the nasopharynx (1-3). In fact, it is thought that 
S. aureus colonizes more than 30% of the human population’s nares (4), and that 
colonization of the nares is increasingly becoming a risk factor for more serious 
infections. While S. aureus is considered a commensal organism, it is also considered 
an opportunistic pathogen because it can cause a plethora of both community and 
healthcare-associated infections ranging from skin and soft tissue infections to more 
serious life-threatening diseases such as bacteremia, infective endocarditis, 
osteomyelitis, necrotizing pneumonia, and septic arthritis under the right conditions (5). 
In fact, S. aureus is now the leading cause of infective endocarditis in the industrialized 
world (6), and a prominent cause of osteomyelitis (5). Collectively, in the United States 
alone, S. aureus is one of the leading causes of all community and healthcare-
associated infections and has caused increased mortality rates and nearly doubles the 
hospitalization time when compared to normal hospital stays (7). As a result, the 
prevalence of these diseases has led to increased costs associated with S. aureus 
infections over the past decade, estimated to be near $450 million annually (8, 9). Thus, 
it is obvious why S. aureus has become one of the most notorious ‘superbugs’ not only 
in the United States, but all across the industrialized world.  
 
 
2 
 
 
 
Antibiotic Resistance 
 In order to cause so many different types of diseases, S. aureus has developed 
some unique virulence factors that aid in its survival and pathogenesis including toxin 
production, secreted enzyme production, host binding proteins, and biofilm formation. 
However, one of the most prominent capabilities is the ability of the organism to acquire 
antibiotic resistance. Starting in the 1940’s, a plasmid-encoded penicillinase plasmid 
emerged, producing penicillin-resistant strains in several hospitals (10, 11). By the 
1950’s and 1960’s as the penicillin-resistant strains continued to spread via the 80-81 
phage-type, penicillin-resistant strains of S. aureus had become a pandemic (12), and it 
was not until the development of methicillin in the early 1960’s that penicillin-strains were 
diminished greatly. However, the emergence of methicillin-resistant S. aureus, 
commonly known as MRSA, followed the wide-spread use of methicillin shortly 
thereafter (13). For decades following, MRSA strains have remained a prevalent cause 
of S. aureus-related infections, and in the 1990s, the emergence of community-acquired 
MRSA (CA-MRSA) strains has sparked an epidemic in the United States (14). Typically, 
disease manifestation of CA-MRSA strains appear to primarily cause skin and soft tissue 
infections in the form of abscess formation or cellulitis in 90% of the individuals with CA-
MRSA infections (15, 16). In the last decades because CA-MRSA related infections 
remain such a persistent problem, the increased use of vancomycin, one of the last 
effective antibiotics against MRSA, has also led to the emergence of vancomycin-
intermediate and vancomycin-resistant (VISA and VRSA) S. aureus strains (17, 18). Due 
to the constant rise in CA-MRSA related infections and the reoccurring emergence of 
different types of antibiotic resistance, it is becoming apparent that S. aureus is an 
astonishingly adaptable pathogen that we must continue to monitor and study.  
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Virulence Factors 
Toxins 
 A major virulence factor that allows S. aureus to cause so many different types of 
diseases is its ability to produce toxins. Indeed, it is one of the most distinguishable 
capabilities that separate S. aureus from most other human pathogens. While several 
bacterial species can usually produce one or two types of toxins, S. aureus produces 
several categories of toxins that range in function from membrane damaging to 
interfering with the function of host cell receptors (19). Perhaps, the most well-known 
toxins are the receptor-mediated membrane damaging toxins that cause cytolysis of 
several host cell types by forming pores in the cell membrane. Within this group, the 
most well-known and well-studied is alpha-toxin (20), which can cause lysis of red blood 
cells and leukocytes (21) by interacting with the A Disintegrin And Metalloprotease 10 
(ADAM10) receptor found on the host cell surfaces (22). Likewise, S. aureus also 
produces a similar group of host cell receptor-mediated pore forming toxins known as 
the bi-component toxin family consisting of the Panton-Valentine leukocidins (PVL), the 
leukocidins LukAB (LukGH) and LukDE, and the gamma-toxins (HlgA, HlgB, HlgC, 
gamma-hemolysin) (23-26). Like receptor-mediated pore forming toxins, a group of non-
receptor-mediated membrane damaging toxins called the phenol soluble modullins 
(PSMs) has recently been discovered. This group of non-specific pore forming toxins 
consists of three groups of δ-toxin, PSMα, and PSMβ all of which have differing 
contributions to pathogenesis via non-specific cytolytic activity (27).  
 The second most well-known group of toxins produced by S. aureus is the toxins 
that interfere with specific receptor functions on host cells. This group is largely 
comprised of the superantigen group of toxins: enterotoxins and the toxic shock 
syndrome toxin (TSST), and the chemotaxis inhibitory protein of S. aureus (CHIPS), 
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which has been shown to function as an immune suppresser by blocking activation of 
the complement system (28). While the exact mechanism of how these toxins work 
remain largely undetermined, the approximately 20 enterotoxin and enterotoxin-like 
proteins produced by S. aureus have been shown to be involved in disturbing proper 
intestinal function and causing food borne illnesses such as vomiting and diarrhea (29). 
While it can also cause food borne illnesses, the superantigen TSST is primarily known 
for its function in causing toxic shock syndrome (30, 31). Like the other enterotoxins, it is 
also thought that TSST by-passes normal antigen presentation by binding MHC II 
proteins and initiating cytokine release (32).    
Secreted Enzymes  
 Another major component included in the arsenal of virulence factors that are 
produced by S. aureus is the numerous secreted enzymes that enable degradation of 
host components or interfere with host molecular signaling. Although Staphylococci 
produce various types of secreted enzymes including proteases, coagulases, kinases, 
and nucleases, perhaps, the most studied are the ten secreted proteases because of 
their various roles in aiding pathogenesis. These ten proteases include seven serine 
proteases (SspA and SplABCDEF), two cysteine proteases (the Staphopains ScpA and 
SspB), and a metalloprotease (Aureolysin). In combination with the reports of affecting 
biofilm integrity in vitro (discussed below) (33), in some instances, the proteases have 
been shown to be important for causing infections. While the basic function of the 
proteases is to cleave both self and host proteins, the overall process in which the 
proteases affect biofilm maturation and pathogenesis remains unclear given the myriad 
of targets of each individual protease. One thought is that the proteases may degrade 
the host proteins for nutrient acquisition to aid in growth under proteinaceous-rich 
environments (34). However, a complete knock out of all ten proteases also showed an 
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increase in S. aureus extracellular virulence factor production and an increase in 
mortality in a systemic mouse model infection (34). Further complicating the 
understanding of protease contribution to pathogenesis is that in some cases individual 
proteases must be auto-activated (35, 36) or rely on a proteolytic cleavage cascade 
activation (37, 38). Nonetheless, it is apparent that the production of the secreted 
proteases plays a complex role in S. aureus pathogenesis that must continue to be 
evaluated.      
 Although not as well studied, other secreted enzymes also have important 
functions in pathogenesis in a number of different ways. For example, the two known 
coagulases, staphylocoagulase and van Willebrand factor (vWF), produced by 
staphylococci are important for forming clots in the blood plasma, inhibiting phagocytosis 
in abscess formation (39), and enhancing adhesion in catheter biofilm-associated 
infections (40). It is thought that the coagulases function by binding and activating 
prothrombin and converting fibrinogen to fibrin leading to the formation of the fibrin blood 
clots (41). And while these appear to be the main functions, staphylocoagulase has also 
been implicated in the formation of S. aureus biofilms grown under shear stress 
conditions (discussed in biofilm section) (42) 
 On the other hand, staphylokinase is thought to degrade fibrin clots generated 
during a S. aureus infection to maintain localization of the infection and allow bacterial 
invasion into deeper tissues (43, 44). It does so by activating plasminogen and 
converting it to plasmin, which may enhance lysis of surrounding host tissues allowing 
bacterial invasion. Additionally, it also aids in S. aureus infections by cleaving and 
inactivating the complement factor, C3b (45). 
 Lastly, while both S. aureus nucleases have continuously been shown to have a 
function in modulating biofilm formation (discussed below), the secreted nuclease (Nuc) 
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has also been shown to have a function in degrading neutrophil extracellular traps 
(NETs) during an S. aureus infection (46, 47). Further evidence for a nuclease as 
potential virulence factor is the recent data demonstrating a decreased bacterial load per 
organ in in mouse peritonitis model (48), although the exact mechanism contributing to 
this phenotype is not well understood.  
  
Bacterial Biofilms  
 In contrast to laboratory conditions, bacteria are rarely grown in a planktonic 
state under nutrient rich conditions. Rather, they are almost exclusively living in nutrient-
deficient environments in multicellular aggregations of cells called biofilms (49, 50). In 
order to form biofilms, bacteria must generate a self-produced extracellular matrix (ECM) 
composed of proteins, carbohydrates, and/or extracellular DNA (eDNA) (51). The ECM 
encases the cells in a sticky agglomeration that facilitates survival in hostile or extreme 
environments including adverse conditions of temperature, pH, therapeutic treatments, 
and/or immune cells within a host (52).  
 To allow survival in such harsh conditions, a fascinating ability of bacterial 
biofilms is the capability to allow single-celled organisms to assume multicellular group 
behavior mediated by complex regulatory networks that react to changes in the 
surrounding environmental or biofilm conditions (53). Indeed, multicellularity has been 
shown in several different bacterial species and provides the organism benefits that it 
would otherwise not typically have including division of labor into distinct cell types (54). 
A recent example of this is the non-pathogenic Bacillus subtilis, which distinctly 
differentiates into separate cell types.  More specifically, B. subtilis has been shown to 
determine differential fates of cells involved in motility, matrix production, sporulation, 
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cell death, cannibalism and competence based on environmental conditions and 
correlating with spatiotemporal control within a developing biofilm (55, 56). Additionally, 
although not known for cell differentiation during biofilm formation, the soil predator 
Myxococcus xanthus has also been shown to coordinate unparalleled cell differentiation 
when ‘swarming’ and forming fruiting body structures when preying on other soil-dwelling 
organisms (57). In addition, individual cells within a biofilm have also been shown to 
differentiate and demonstrate genetic and physiologic heterogeneity based on 
differences in microscale chemical gradients, local environmental conditions, and 
stochastic gene expression (58).  Although complex and varying across bacterial 
species, the conditions within the biofilm and regulatory processes are largely sensed 
and coordinated by two-component (59) and quorum sensing systems. In particular, the 
quorum sensing systems enable cells to communicate to each other to coordinate cell 
differentiation and gene expression based on self-produced cell density signals known 
as autoinducers (60). Overall, it is abundantly clear that biofilms that enable 
multicellularity processes that are dependent on a plethora of environmental sensing and 
quorum sensing mechanisms. 
 Typically, bacterial biofilm development is described in three successive stages: 
1. attachment, 2. accumulation/maturation, and 3. detachment/dispersal (53, 61). During 
the initial attachment stage, planktonic cells adhere to a biotic or abiotic surface and 
proliferate into sticky aggregations called towers (also known as microcolonies). As 
these aggregations develop, bacterial cells produce an ECM that serves as a scaffold to 
determine three-dimensional architecture. Upon reaching a specific density, a 
mechanism is triggered to initiate ECM modulation to allow cells embedded within the 
biofilm ECM to detach and disperse to seed other environment to reinitiate biofilm 
development.  
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 In recent years, bacterial biofilms produced by human pathogens have become 
particularly important to study due to their increase recalcitrance, to not only the host 
immune system and antimicrobial peptides (62), but to antibiotics and other therapeutic 
treatment (63, 64). Despite the prevalence of these biofilm-associated infections, the 
molecular mechanisms that control the steps of biofilm development are still being 
investigated.  
Staphylococcal Biofilms 
 Like other human pathogens, Staphylococcus aureus has progressively become 
notorious for causing chronic nosocomial infections due to its ability to resist therapeutic 
treatment by forming biofilms on both indwelling medical devices including implanted 
artificial heart valves, pacemakers, catheters and joint prosthetics (65, 66). Indeed, 
nearly half of all nosocomial infections are associated with indwelling device infections 
(67). In addition, S. aureus has also developed the ability to form biofilms on host bone 
tissue and heart valves possibly leading to osteomyelitis and endocarditis infections, 
respectively (68).  To cause such persistent infections, not only does the ECM of S. 
aureus biofilms provide a physical barrier to protect staphylococcal cells from antibiotic 
therapy and host immune system infiltration, but recent data also suggest that S. aureus 
biofilms actively skew the immune system limiting macrophage invasion in vivo and 
contributing to bacterial persistence (69-73). In addition, the metabolic state of the cell 
also enables persistence of bacterial cell in response to antibiotic treatment (74). Since 
antibiotics generally target metabolically active dividing cells, the formation of 
metabolically dormant cells known as persisters add another component to S. aureus 
biofilms abilities to resist antibiotic treatment independent of other encoded antibiotic 
resistance mechanisms (75). Thus, a continued understanding of the development of 
staphylococcal biofilms at the molecular level remains a high priority.  
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Stages of Staphylococcus aureus Biofilm Development 
Attachment Stage 
 Like other bacterial biofilm development, S. aureus is thought to form biofilms in 
three sequential stages: 1. attachment, 2. accumulation/maturation, and 3. 
dispersal/detachment (76). During attachment, planktonic cells adhere to either abiotic or 
biotic surfaces. When attaching to biotic surfaces such as matrix components of the host 
tissue, S. aureus is thought to utilize a variety of different surface proteins specific for the 
host matrix substrates. A well-characterized group of surface anchored proteins known 
as the microbial surface components recognizing adhesive matrix molecules 
(MSCRAMMs) facilitate attachment to host matrix component such as fibronectin, 
fibrinogen, collagen, and cytokeratin (77). Specific examples of MSCRAMMs include the 
fibronectin-binding proteins (FnBPA and FnBPB) (78), the serine-aspartate repeat family 
proteins (SdrC, SdrD, and SdrE) (79, 80), the clumping factors (ClfA and ClfB) (81, 82), 
the collagen adhesin (83), and the bone sialo-binding protein (Bbp) (84). Additionally, 
while the primary purpose of MSCRAMMs is to bind host proteins and potentially initiate 
biofilm formation, it is also becoming more prevalent that these proteins also have 
additional functions which aid in pathogenesis including immune evasion (77).   
 S. aureus produces several surface proteins such as the MSCRAMMs that play a 
significant function in adhesion and initial accumulation to host matrix components, yet, 
more recent data suggests that these proteins play a less significant function in 
attachment to abiotic materials such as polystyrene or a glass. This is not a surprise 
considering the host matrix substrates important for MSCRAMM binding are absent 
when cells are binding to these types of abiotic surfaces. Recently, three different types 
of molecules have been implicated in binding to abiotic surfaces. First, a mutation in the 
Agr quorum sensing circuit, typically known for its function in biofilm dispersal by 
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regulating the PSMs (discussed below), was previously shown to inhibit attachment to 
polystyrene by preventing hydrophobic interactions between the cell and the polymer 
surface via limited production of the PSM δ-toxin (85). Second, like δ-toxin, the major 
autolysin AtlA has also been proposed to aid in cell attachment, (86, 87) although the 
multi-functionality of this protein makes it difficult to determine the exact mechanism of 
attachment. Lastly, there is some data to suggest that S. aureus teichoic aids also have 
a function attachment mediated by charge interactions with an abiotic surface (88). 
Accumulation/Maturation Stage  
 During the accumulation/maturation stages of biofilm development, S. aureus 
begins to create the ECM composed of polysaccharide intercellular adhesin (PIA), 
eDNA, and/or proteins which allow cells within the biofilm to stick together and form 
three-dimensional structures. Possibly the most studied of these ECM components, PIA, 
produced by the icaADBC operon, has been shown numerous times to have a function 
in the accumulation and maturation of S. aureus biofilms (89-91). Yet, it appears to be 
strain- or condition-specific, given the number of strains that have also been shown to 
form PIA-independent biofilms (92-94). While PIA cannot be completely disregarded for 
its function in S. aureus biofilms, it appears that PIA-independent S. aureus biofilms may 
rely more on proteins and eDNA (95-97) than the closely related species 
Staphylococcus epidermidis. 
 Other components to consider as possible constituents of the ECM during early 
biofilm development are intracellular components. In support of this, a recent report 
demonstrates that S. aureus biofilms appear to recycle cytoplasmic proteins not typically 
characterized as biofilm-related proteins such as enolase and GAPDH which are 
somehow released into the extracellular milieu to attach to the surface of the cell (98). 
Although the mechanisms of how cytoplasmic proteins devoid of a signal peptide can be 
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transported into the extracellular milieu still remains unknown, the authors speculate that 
the accumulation of these moonlighting proteins in the ECM may be associated with 
mechanisms of autolysis-mediated release of eDNA. This may be a likely scenario 
considering eDNA release mediated via cell death and lysis by the cidABC and lrgAB 
operons and atlA has been shown to play a significant determinant in S. aureus biofilm 
structuring (discussed in detail below) (99-104). In conjunction with eDNA release, there 
are reports of proteins interacting with the eDNA within the ECM to provide the biofilm 
with structural support. Two recent examples include the moonlighting cytoplasmic 
proteins, enolase and GAPDH, binding to eDNA under low pH conditions (105) and the 
presence of eDNA to initiate PSM-mediated amyloid fiber production (106). In addition, 
there is data to suggest that cytoplasmic nucleoid-associated proteins (NAPs), typically 
used for chromosomal structuring, may also serve as a biofilm scaffold when released 
from the cell by binding eDNA (107). Likewise, other extracellular proteins such as beta-
toxin (Hlb) (108) and the immunodominant surface antigen B (IsaB) (109) also have 
shown the ability to bind eDNA and potentially play a role in biofilm scaffolding. 
Detachment/Dispersal Stage  
 During the last stage of biofilm development, the S. aureus cells switch from a 
biofilm state of growth to planktonic cells by detaching from the biofilm and dispersing to 
other sites to potentially start the biofilm process over. Normally, this process is thought 
to be controlled by the modulation or degradation of the ECM. Indeed, dispersal of S. 
aureus biofilms has been shown to be under the control of the Agr, quorum sensing 
network (85, 110) which controls several genes associated with ECM modulation. The 
first studies examining the contribution of the Agr system in S. aureus biofilm 
development demonstrated that agr-deficient strains developed more robust biofilms 
when compared to their wild-types counterparts (85) suggesting that the Agr system may 
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play a potential role in detachment of biofilms. Yet, it was not until flow-cell studies 
evaluating to role of Agr quorum sensing during S. aureus biofilm development that a 
more direct role was identified. More specifically, time-lapse microscopy identified that 
the P3 promoter was differentially expressed in a subpopulation of cells located primarily 
in the tower/microcolony portions of the biofilm. Additionally, P3 expression appeared to 
oscillate in waves over time coinciding with detached cells of the biofilm (110). While this 
initial report provided support that agr activity plays a role in dispersal of biofilms, the 
agr-regulated factors that mediate dispersal still remained unclear. It wasn’t until later in 
which two independent studies provided evidence of contrasting modes of agr-mediated 
dispersal mechanisms. In one study, it was shown that the Agr system regulates 
expression of secreted proteases that degrade proteinaceous components of the ECM in 
order to disperse the biofilm. It was also demonstrated that there was a direct correlation 
of P3 activation via induction by AIP and dispersal of intact biofilms which they propose 
is due to increased protease activity (111). While this provides a connection with 
protease activity, Agr is not the only known regulator of the secreted proteases. In fact, 
other master regulators such as SarA, SigB, SaeRS, and Rot (33, 112-115) have all 
been shown to mediate protease activity and biofilm maturation. 
 An alternatively proposed agr-dependent dispersal mechanism is the production 
of the PSM peptides. These short amphipathic, α-helical peptides have been shown to 
be under the regulation of Agr system via direct binding of AgrA to the psm operon 
promoters, and under certain growth conditions, have been implicated in dispersing 
staphylococcal (116, 117). Indeed, S. aureus isogenic mutants in the either classes of 
PSMα or PSMβ or δ-toxin demonstrated more robust biofilm formation (117). Like the 
Yarwood et al. study, it was also shown that the induction of the Agr-system and the psm 
operon promoters correlates with waves of dispersal during late stages of biofilm 
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development (117). It is thought that when PSMs are produced that they act like 
surfactants disrupting covalent interactions within the biofilm matrix to mediate dispersal 
(27, 76). While the surfactant-like properties of the PSMs may indeed be the major 
player in biofilm dispersal, there is also contrasting evidence suggesting that under 
certain conditions that aggregation of the PSMs into nonsoluble amyloid-like fibers might 
abrogate biofilm dispersal and contribute to the integrity of the biofilm structure (118). 
Hence, the production of PSMs solely may not initiate dispersal, but rather the state in 
which the PSMs are assembled may contribute directly to the biofilm disassembly. 
Additionally, it is also apparent that the presence to of eDNA promotes the formation of 
these amyloid-like structures (106) suggesting a necessity for the production and 
interplay between ECM components to allow proper biofilm development. 
 Apparently separate from the Agr-mediated dispersal mechanisms, the 
production of two extracellular nucleases also have a function in biofilm detachment. 
eDNA is an important component of the ECM, and several studies have demonstrated 
that both the secreted nuclease (Nuc) and suface-attached nuclease (Nuc2) degrade 
eDNA initiating biofilm dispersal (100, 119-122). However, the studies in this dissertation 
demonstrate that nuclease-mediated detachment may be important form proper 
maturation under certain conditions, rather than an endpoint like Agr-mediated 
processes. 
Mechanisms of cell death and lysis 
The existence of pronounced death and lysis during bacterial biofilm 
development has led to the proposal that these relatively simple organisms have the 
capacity to control cell viability in a process analogous to apoptosis in more complex 
eukaryotic organisms (123, 124). A key function of these processes, referred to as 
bacterial programmed cell death (PCD), is likely to release genomic DNA into the biofilm 
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matrix, where it serves as an effective intercellular adherence molecule. The importance 
of extracellular DNA (eDNA) as a matrix molecule was originally demonstrated in 
Pseudomonas aeruginosa (125) and has since been shown to be important for biofilms 
produced by a wide range of bacterial species (99, 100, 125-129). Although some 
reports suggest the involvement of bacteriophage in DNA release during biofilm 
development (129-132), the presence of distinct regions of cell death and lysis indicates 
that this process is highly regulated (100, 126, 129, 133).  
Insight into the molecular mechanisms controlling PCD has come from studies of 
the S. aureus cidABC and lrgAB operons, which were originally characterized as 
mediators of murein hydrolase activity and lysis (134-136). The mode of action of their 
gene products has been hypothesized to involve a mechanism analogous to the holin-
/antiholin-mediated control of host cell lysis during bacteriophage infection (123, 137). A 
role for these operons during biofilm development was demonstrated by the 
observations that cid and lrg mutations affect biofilm formation, disrupting the normal 
architecture that is a characteristic of these multicellular communities (99, 100). 
Additionally, it was established that the cid mutant produced biofilm with reduced levels 
of matrix-associated eDNA, while the lrg mutant exhibited increased levels of this matrix 
component (100). Similar effects on biofilm development were also produced by 
Pseudomonas aeruginosa in which homologues of cid and lrg had been disrupted (138). 
These results suggest the existence of a careful balance between death effectors and 
inhibitors in normal biofilm, not unlike that proposed to control normal tissue 
homeostasis in more complex developmental organisms (124). Moreover, they support 
the notion that this mechanism is conserved in other bacterial species.  
Recent evidence also suggests that Cid-/Lrg-like proteins are conserved much 
more broadly than was originally recognized. Recent studies of a putative Arabidopsis 
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CidAB/LrgAB homolog, designated AtLrgB, indicated that this gene is an important 
regulator of cell death in plants (139, 140). Disruption of the gene encoding AtLrgB 
produced plants with interveinal chlorotic and premature necrotic leaves, suggesting the 
involvement of this protein in leaf senescence. Furthermore, recent studies (141) also 
support the model that the mammalian Bcl-2 family of proteins functions in a manner 
analogous to holins and antiholins. Strikingly, these studies demonstrated that the death 
effector and inhibitor components of the Bcl-2 protein family can induce cell death and 
lysis in Escherichia coli similar to holins and antiholins, respectively. Indeed, 
replacement of the normal holin of bacteriophage lambda with derivatives of human Bax 
protein resulted in the formation of functional, plaque forming viral particles. These 
results suggest that the functions of the Cid and Lrg proteins span at least three 
Kingdoms of life. 
 It is clear that any model of controlled cell death and lysis during biofilm 
development must accommodate the observation that only a subpopulation of cells 
undergoes this process. Structured biofilms exhibit obvious spatial differences in cell 
viability and lysis, including localized dead cell and eDNA staining in towers and more 
homogeneous live cell populations in the basal biofilm (100, 126, 129, 133). This has led 
us to hypothesize that the differential expression of cell death and lysis within biofilm 
subpopulations is dictated by the heterogeneous expression of the cid and lrg operons 
within the biofilm (123, 124), possibly as a result of the metabolic heterogeneity 
commonly observed in them (142). The combined effects of metabolism are envisioned 
to result in an optimal balance of expression that is essential for normal biofilm 
development (124). Indeed, expression of the S. aureus cidABC and lrgAB operons has 
been shown to be tightly coordinated by regulators that sense and respond to basic 
metabolic processes. For example, cidABC expression is induced by the LysR-type 
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transcriptional regulator, CidR, under conditions of excess glucose and oxygen (overflow 
metabolism) (143-145), while lrgAB expression is stimulated by changes in membrane 
potential in a process that is dependent on the two-component regulatory system, LytSR 
(146). Although much is known about the regulatory signals important in cidABC and 
lrgAB expression, how these signals are integrated during biofilm development remains 
unknown. 
BioFlux1000 microfluidic technology1 
 Given the propensity at which staphylococci develop biofilms and cause chronic 
infections, assays to aid in the understanding the molecular mechanisms in biofilm 
maturation are essential. Above all, biofilm assays designed to evaluate biofilm 
development in a real-time manner are of becoming particularly essential. The new gold 
standard for assessing developmental processes associated with biofilm formation are 
flow-cell systems that allow for the perfusion of media across bacterial cells attached to 
a synthetic surface, thus, providing a constant supply of nutrients under the pressure of 
a shear force.  Today, several commercially available flow-cell systems from companies 
such as BioSurface Technologies, Corp., Stovall Life Science, Inc., and Fluxion 
Biosciences, Inc. are available for use in biofilm studies. In fact, a variety of flow-cell 
systems ranging from single to multi-channel designs are available in either reusable or 
disposable forms. While some flow-cell systems allow researchers to test the effects of 
various surfaces such as glass slides/coverslips, polycarbonate coupons, and plastic 
capillary tubing on biofilm development, others are designed to maximize versatile image 
acquisition using a high-throughput plate format. An example of this is the microfluidic 
system the BioFlux1000. The BioFlux1000 is comprised of an epifluorescence 
                                                          
Majority of this section has been published in Derek E. Moormeier and Kenneth W. 
Bayles. 2014. Methods Mol Biol. 
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microscope equipped with an automated temperature-controlled stage, a pneumatic 
compressor, a high-resolution camera, and specialized 24-well or 48-well plates 
equipped with microfluidic channels that connect two adjacent wells, one for sterile 
media and the other for effluent (Figure 1-1) (147).  The microfluidic channels are 
seeded with bacteria and the sterile media is pneumatically perfused through the 
channels, resulting in biofilm growth.  To assess biofilm development in each channel 
(up to 8 or 24 biofilms, depending on the plate being used), sequential images are 
automatically acquired using the high-resolution camera and compiled using BioFlux 
Montage image analysis software. Collectively, the automated image acquisition and the 
simultaneous growth of multiple biofilms enable an unprecedented comparison of biofilm 
development by bacterial strains containing different mutations. Additionally, the use of 
metabolic stains and/or fluorescent reporters allows for the localization of spatial and 
temporal patterns of metabolic activity and gene expression within the developing biofilm 
architecture (147, 148).  Although the evaluation of the biofilm images is primarily 
qualitative, the BioFlux data analysis software contains some functions that enable areas 
of the two-dimensional images of light and/or fluorescence intensity to be quantified 
(147). In these studies, we took advantage of the BioFlux1000 capabilities to maximize 
evaluation of S. aureus biofilm in real time. 
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Figure 1-1 BioFlux1000 Interface, Gasket, Tubing, Stage, and 48-well plate setup 
 
The BioFlux Interface locks the BioFlux plate to the heated stage and is connected to the 
BioFlux Controller via small tubing. The tubing allows media to be pneumatically pumped 
into the microfluidic channels of the BioFlux plate. It is important during every attachment 
of the BioFlux Interface to the BioFlux Plate to apply as little pressure as possible to the 
top of the Interface to prevent the plate from cracking. 
 
Figure modified from Derek E. Moormeier and Kenneth Bayles. 2013. Methods Mol Biol. 
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CHAPTER II: 
MATERIALS AND METHODS 
Table 1. Bacterial strains and plasmids used in these studies 
Bacterial Strains  Description Reference 
Escherichia coli   
DH5α Host strain for construction of recombinant plasmids (149) 
   
S. aureus   
RN4220 Highly transformable strain; restriction-deficient (150) 
UAMS-1 Wild-type osteomyelitis clinical isolate (151) 
UAMS-1471 UAMS-1 ∆nuc (112) 
UAMS-155 UAMS-1 agr::tet (152) 
UAMS-1 hsdR- UAMS-1 restriction-deficient  (153) 
KB999 UAMS-1 lytS::ermC (146) 
KB1090 UAMS-1 cidR::ermC (145) 
*KB8037 UAMS-1 icaA:: ΦΝΣ This study 
KB8000 UAMS-1 ∆ackA::ermB, Ermr (154) 
KB8001 UAMS-1 ∆pta (154) 
USA300 LAC JE2 USA300 LAC derivative (155) 
JE2 agrA:: ΦΝΣ  bursa aurealis agrA mutation in JE2 (155) 
JE2 nuc::ΦΝΣ bursa aurealis nuc mutation in JE2 (155) 
JE2 atlA::ΦΝΣ bursa aurealis atlA mutation in JE2 (155) 
AH1263 USA300 CA-MRSA Erms LAC derivative (97) 
AH1558 AH1263 saeQRS::spc (48) 
AH1919 AH1263 Δaur ΔsspAB ΔscpA spl::erm (protease KO) (156) 
AH2216 AH1263 ∆saePQRS (157) 
**CFS93 AH1263 ∆saeP Horswill lab 
**AH3499 AH1263 ∆saeQ Horswill lab 
AH3500 AH1263 ∆saeS (157) 
   
Plasmids   
pCR2.1 E. coli PCR cloning vector Invitrogen 
pJB38 Temperature sensitive allelic exchange plasmid (158) 
pBK123 Shuttle vector, pCN51ΔEM::CAT; CmR (159) 
pEM64 pBK123 derivative containing Cd-inducible GFPaav This study 
pEM80 lrgAB promoter::sGFP, CmR This study 
pEM81 cidABC promoter::sGFP, CmR This study 
pEM87 ldh1 promoter::sGFP, CmR This study 
pCM11 Shuttle vector encoding sGFP (160) 
pKH4 Agr P3 promoter::sGFP (161) 
pDM4 lrgAB promoter::sDsRed, cidABC promoter::sGFP This study 
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pSC14 sarA promoter::sDsRed, cidABC promoter::sGFP Thomas lab 
pDM17 sarA promoter::sDsRed, nuc promoter::sGFP This study 
pDM19 coa promoter::sDsRed, nuc promoter::sGFP  This study 
pCM20 nuc promoter::sGFP (119) 
pCM27 hla promoter::sGFP (157) 
pCM11hlgA hlgA promoter::sGFP (157) 
pCM11P1sae P1sae promoter::sGFP (157) 
pRMC2 anhydrotetracycline inducible plasmid (112) 
pRMC2-nuc anhydrotetracycline inducible plasmid containing nuc (119) 
**pJB38-∆saeP AH1263 ∆saeP allelic exchange plasmid Horswill lab 
**pJB38-∆saeQ AH1263 ∆saeQ allelic exchange plasmid Horswill lab 
*Strain constructed by Jennifer L. Endres from Bayles laboratory, but has not yet 
been published. 
**Strains and plasmids constructed in Dr. Alexander Horswill laboratory by Dr. 
Caralyn Flack, but have not yet been published. 
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Table 2. Oligonucleotides 
Primer Name Sequence 
cidA-pro-F 5’-CCCGCATGCAGCAAATTATCAATGATGAAGTAGATA-3’ 
cidA-pro-R 5’-CCCGGATCCCGCCATCCCTTTCTAAATAC-3’ 
lrgA-pro-F 5’-CCCGCATGCCGATAAAATTCACATGTTAAAGC-3’ 
lrgA-pro-R 5’-CCCGGATCCCGTTTGATTTAACTAAAGTATAGATGG-3’ 
ldh1-pro-F 5’-CCCGCATGCATGGCTTTTAATAAATTTTC-3’ 
ldh1-pro-R 5’-CCCGGATCCTACAAAAACTCCCTTATGAT-3’ 
cidA-rt-F 5’-GGGTAGAAGACGGTGCAAAC-3’ 
cidA-rt-R 5’-TTTAGCGTAATTTCGGAAGCA-3’ 
lrgA-rt-F 5’-GCATCAAAACCAGCACACTTT-3’ 
lrgA-rt-R 5’-TGATGCAGGCATAGGAATTG-3’ 
sigA-rt-F 5’-AACTGAATCCAAGTCATCTTAGTC-3’ 
sigA-rt-R 5’-TCATCACCTTGTTCAATACGTTTG-3’ 
DsRed-F 
5’CAGAGTCGACTGATTAACTTTATAAGGAGGAAATACATATGGAC
AACACCGAGG-3’ 
DsRed-R 5’-ACATGCATGCTACAGGAACAGGTGGTGGCGG-3’ 
sGFP-F 
5’CACGAATTCTGATTAACTTTATAAGGAGGAAAAACATATGCCCG
GGAGCAAAGGAG-3’ 
sGFP-R 5’-CCTGGCGCGCCTTCTTATTTGTAGAGCTCATCCATGCC-3 
lrgA-R 5’-GCTGGATCCACGTTTGATTTAACTAAAGTATAGATGGCTCAC-3’ 
cidA-R 
5’GCCGGAATTCTAAATACGTCTAAATTGTTACAATAACTATTATAA
AGATGGCG-3’ 
cidABC-lrgAB-
F 
5’GTTTCCAGTCCATTCAAGCGTTCCGCACATGACCAATACGCAGT
ACAG-3’ 
lrgAB-cidABC-
F 
5’CTGTACTGCGTATTGGTCATGTGCGGAACGCTTGAATGGACTG
GAAAC-3’ 
sDsRed-F 5’-AGCGGATCCAGATAATCTATAAAAGGAGG-3’ 
sDsRed-R 5’-TCTTGCATGCTTATAAAAACAAATGATGACGAC-3’ 
MJT240 5’-GTTGTTGAATTCACCTGTATACATTACAGACC-3' 
CEF169 
5'CAGAAATTGAGTACTAGATCTGTATTCATGCTAACTCCTCATTTC 
- 3' 
CEF170 
5’GAATACAGATCTAGTACTCAATTTCTGAGTTAAACTTTTATTTAC
AAC- 3' 
CEF171 5’- GTTGTTGGTACCAAGAAACTAGCAGCATATGC - 3' 
CEF172 5' - GTTGTTGAATTCCCTAACAGGTACATTCAGTTC -3' 
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CEF173 
5'GCGAGTACTAGATCTCATTCTTTCTATTTATTGTGTGTAATTTAT
AT - 3' 
CEF174 5' - AGAATGAGATCTAGTACTCGCAAATATAGTTGCACATAC - 3' 
CEF175 5’- GTTGTTGGTACCGATGGTATATGTTGTAAAGCTCTC - 3' 
icaA-F 5’-CATTGAACAAGAAGCCTGAC-3’   
icaA-R 5’-CTGCTGTATTATCTGAACTTCC-3’ 
Type III-F 5’-CATCGAATGCGTTAAAGGTTAATTATGAGC-3’ 
Type III-R 5’-CACTATCGTCTCCTGTTAAAGCAACAC-3’ 
cna-F 5’-AGTGACATGGTCTAATCTTCCGG-3’ 
cna-R 5’-TCCACTTTTGATGGCTTATCTGG-3’ 
Dual-coa-F 5’-GCCGCTGCAGGTTTCGCTTTAGTCATTTGAT-3’ 
Dual-coa-R 5’-GCCGGGATCCATGTAATTGCCCAATCTACAT-3’ 
Dual-nuc-F 5’-GCCCGCTGCAGGTAAATTATAAGTTATACATCTCG-3’ 
Dual-nucR 5’GCCGGAATTCCTTTTTAGTTAATTTTAATATTAAACG-3’ 
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Bacterial strains and growth conditions 
 Staphylococcus aureus and Escherichia coli strains used in these studies are 
described in Table 1. All strains of E. coli were grown in Luria-Bertani broth (LB) or LB 
containing 1.5% agar. All S. aureus strains were grown in tryptic soy broth (TSB) (EMD 
Biosciences, Gibbstown, NJ) or on TSB containing 1.5% agar. All experiments were 
started from fresh overnight TSB cultures grown at 37°C with shaking at 250 rpm. To 
determine expression of fluorescent reporters fusions in Chapter III by planktonic aerobic 
growth, cultures were generated by inoculation of overnight cultures into TSB medium 
with or without glucose to an OD600 of 0.1 and incubation with shaking at 250 rpm at 
37˚C using a 10:1 flask to volume ratio. Hypoxic growth was achieved by growing the 
cells statically at 37˚C in a covered flask at a 5:3 flask to volume ratio. Dissolved oxygen 
levels were measured using a portable dissolved oxygen meter (Accumet) per the 
manufacturer’s instructions.  As needed, chloramphenicol (5 µg ml-1), erythromycin (5 µg 
ml-1), tetracycline (5 µg ml-1), ampicillin (100 µg ml -1), and spectinomycin (1000 µg ml-1) 
were added to the growth medium.  
 
Planktonic growth analysis of S. aureus sae mutations 
 To determine any growth defects of sae mutations during planktonic aerobic 
growth described in Chapter III, cultures were generated by adjusting overnight cultures 
to an OD600 0.06 in TSB containing 0.25% glucose and then grown for 24 hours with 
shaking at 250 rpm at 37°C using a 10:1 flask to volume ratio. Subsequently, 
supernatants were taken at 0, 3, 6, 9, 12 and 24 hours and the OD600 were measured 
and plotted over time. 
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Determination of exogenous DNA growth and nuc expression on planktonically 
grown AH1263 and sae mutant cells 
 At a flask ratio of 10:1, S. aureus overnights were adjusted to OD600 0.06 in 25 ml 
of TSB containing 0.25% glucose buffered in 50 mM 3-(N-morpholino)propanesulfonic 
acid (MOPS) at a pH 7.4 with or without different percentages of exogenous salmon 
sperm DNA. Cultures were agitated at 250 rpm and grown for up to 24 hrs. To determine 
the effect on growth and relative fluorescence, OD600 supernatants were read first. Next, 
another supernatant of cells were washed once in 1x PBS and 200 µl were pipetted into 
a 96-well flat-bottom, black polystyrene plate (COSTAR 3916). Fluorescence was 
quantified using a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of 
490 nm and emission wavelength of 525 nm. Relative fluorescence was determined by 
normalizing the quantified fluorescence per OD600 and plotted using GraphPad Prism. To 
determine the effect of exogenous DNA on solely growth, the OD600 were plotted over 
time using GraphPad Prism. 
 
Generation of transcriptional reporter fusions 
The S. aureus cidABC, lrgAB, and ldh1 promoter regions were PCR-amplified 
using oligonucleotide primers flanking these sequences and Thermolace high fidelity 
DNA polymerase (Invitrogen, Carlsbad, CA). Specifically, a 689 nt DNA fragment 
spanning the promoter region of cidABC (PcidABC), and a 500 nt DNA fragment spanning 
the promoter regions of lrgAB (PlrgAB) and ldh1 (Pldh1), were amplified using the cidA-pro, 
lrgA-pro, and ldh1-pro primer sets, respectively, listed in Table 2. Each promoter 
fragment was ligated into pCR2.1 using the Invitrogen TA cloning kit (Carlsbad, CA) and 
the recombinant plasmids were transformed into E. coli DH5α cells (Table 1). After 
confirming the absence of mutations by nucleotide sequencing, the promoter fragments 
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were excised by digestion with the restriction endonucleases, SphI and BamHI, and 
used to replace the cadmium-inducible promoter in front of the gene encoding the short 
half-life GFPaav in the plasmid, pEM64. Due to the weak fluorescence of GFPaav, the 
GFPaav gene was replaced with the gene encoding superfolder GFP (sGFP) from 
pCM11 (Table 1).  
A dual reporter plasmid (designated pDM4) containing divergently transcribed 
cidABC and lrgAB promoter regions fused to genes encoding green and red fluorescent 
proteins, respectively, was constructed as follows. Primers DsRed-f and DsRed-r (Table 
2) were used to amplify the gene encoding DsRed.T3(DNT) fluorescent protein (162).  
The 717 bp DsRed.T3(DNT) PCR product was ligated into the SalI-SphI sites of the 
shuttle vector, pBK123 (Table 1), producing pDM1. Using primers lrgA-r, cidA-r, cidABC-
lrgAB-f, and lrgAB-cidABC-f (Table 2), the promoter regions spanning 833 bp and 602 
bp upstream of cidABC and lrgAB, respectively, were amplified from the S. aureus 
UAMS-1 chromosome and combined using a SOEing (splicing by overlap extension) 
technique (163) resulting in a 1,441 bp DNA fragment containing the cid and lrg 
promoters in a divergent orientation. After confirmation of this fragment by nucleotide 
sequencing, it was ligated into the EcoRI and BamHI sites of pDM1 to generate pDM2. 
Next, a 768 bp DNA fragment encoding sGFP from pEM80 was amplified using the 
primers, sGFP-r and sGFP-f (Table 2), and then ligated into the EcoRI and AscI sites of 
pDM2, generating pDM3. Finally, due to the weak expression of the gene encoding 
DsRed.T3(DNT), the coding region was optimized for codon usage in S. aureus, and 
synthesized by Invitrogen-GeneArt (Carlsbad, CA). This gene was then used to replace 
the un-optimized DsRed.T3 (DNT) gene in pDM3, resulting in the plasmid, pDM4. 
The generation of pDM19 was performed as follows. First, pDM17 was 
generated by amplifying the promoter region 319 bp upstream of nuc transcription start 
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site from the AH1263 chromosome using the Dual-nuc-F/Dual-nuc-R primer pair (Table 
2). After amplification of the nuc promoter region, it was digested with EcoRI and PstI 
and ligated into pSC14, resulting in the dual reporter PsarA::sDsRed and Pnuc::sgfp 
plasmid pDM17 (Table 1). Upon confirmation, 455 of the coa promoter region was 
ampilified from the AH1263 chromosome using the Dual-coa-F/Dual-coa-R primer pair 
(Table 2). This 445 promoter region was then digested with PstI and BamHI and ligated 
into pDM17. The resulting plasmid, Pcoa::sDsRed and Pnuc::sgfp dual reporter plasmid, 
was named pDM19 (Table 1).    
 
Generation of icaA::ΦΝΣ mutation in UAMS-1 S. aureus2 
 The UAMS-1 icaA::φΝΣ mutant was generated via transduction using φ11 
propogated in the Nebraska Transposon Mutant Library (NTML) mutant, NE37 (155). 
Due to issues moving the icaA::φΝΣ transposon into wild-type UAMS-1, initially, the 
mutation was transduced into a UAMS-1 restriction deficient isolate (153) as described 
below. Resulting colonies were screened for transposon insertion utilizing primer pair, 
icaA-F and icaA-R. The transduction process procedure was repeated to move the 
mutation from the UAMS-1 restriction deficient strain into the wild-type UAMS-1 
background. These transductants were confirmed to be UAMS-1 background by PCR 
amplification of the UAMS-1-specific cna gene with the primer pair cna-f and cna-R and 
primers specific for the type III restriction system, Type III-F and Type III-R. The resulting 
strain was named KB8037. 
 
                                                          
The construction of this strain was performed by Jennifer Endres in the Bayles 
laboratory, but has not yet been published. 
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Construction of ∆saeP and ∆saeQ mutations in AH1263 S. aureus3 
 To construct the ∆saeP mutant in AH1263, two-step overlap PCR was used to 
create pJB38-∆saeP. 600 bp regions directly upstream and downstream of saeP were 
amplified from AH1263 genomic DNA with primer pairs MJT240/CEF169 or 
CEF170/CEF171 respectively, where CEF169 and CEF 170 contained complementary 
overlap regions (Table 2). The upstream and downstream PCR products were purified 
by agarose gel electrophoresis. 2ml of each purified product were mixed and used as 
the template for the second round of PCR with primer pair MJT240/CEF171. The 
resulting 1.2kb PCR product was purified, digested with EcoRI and KpnI and ligated into 
similarly digested pJB38 (158). The resulting plasmid was used to construct a 
markerless ∆saeP strain in the AH1263 background as previously described (158) and 
was named CEF93 (Table 1). 
 Similarly, to construct the ∆saeQ mutant in AH1263, two-step overlap PCR was 
used to create pJB38-∆saeQ 600 bp region directly upstream and 900 bp region 
downstream of saeQ were amplified from AH1263 genomic DNA with primer pairs 
CEF172/CEF173 or CEF174/CEF175 respectively, where CEF172 and CEF175 
contained complementary overlap regions (Table 2). The upstream and downstream 
PCR products were purified by agarose gel electrophoresis. 2ml of each purified product 
were mixed and used as the template for the second round of PCR with primer pair 
CEF172/CEF175. The resulting 1.2kb PCR product was purified, digested with EcoRI 
and KpnI and ligated into similarly digested pJB38 (158). The resulting plasmid was 
used to construct a markerless ∆saeQ strain in the AH1263 background as previously 
described and was named AH3499 (Table 1). 
                                                          
The construction of these strains was performed by Dr. Caralyn Flack in the 
laboratory of  Dr. Alexander Horswill (University of Iowa), but has not yet been 
published. 
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Movement of plasmids into S. aureus strains 
 All plasmids were purified from the S. aureus strains or E. coli strains using the 
Wizard Plus SV Minipreps DNA purification system (Promega Corporation) according to 
manufacturer’s instructions, and then electroporated into the highly transformable, 
restriction-deficient S. aureus strain RN4220 (Table 1). Transduction of the plasmids 
(Table1) into UAMS-1, JE2, or AH1263 (or mutant derivatives) strains was performed 
using φ11 phage propagated on the plasmid-containing RN4220 strain as previously 
described (164). 
 
Confocal microscopy imaging of planktonic expressing reporter S. aureus strains 
Planktonic S. aureus cells expressing fluorescent reporter genes were imaged by 
CLSM as follows. Overnight cultures were diluted to an OD600 of 0.1 into fresh medium 
and incubated under aerobic and hypoxic conditions as described above. Samples of the 
cultures were harvested and pelleted by centrifugation at 14,000 × rpm for 3 min. The 
pellets were resuspended in 0.85% NaCl to an approximate OD600 of 5.0, and 2.5 µl of 
each preparation was placed on a microscope slide and covered with a coverslip. An 
inverted Zeiss 510 Meta CLSM fitted with a Plan-Apochromat 63×/1.40 Oil DIC M27 
objective set to a 3.0× digital zoom was used to image the cells. An argon 488 nm laser 
was used to excite any GFP present in the cells and the emissions were collected using 
a 505-550 band pass filter. Images collected were processed using the Imaris 7.0.0 
software suite (Bitplane, Saint Paul, MN).  
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RNA quantification  
Total S. aureus RNA was isolated as previously described (146) with minor 
modifications as follows. Briefly, S. aureus cells were harvested by centrifugation at 
4,100 r.p.m. in a Sorvall Legend table-top centrifuge (Newtown, CT) and the resulting 
pellets were resuspended in 500 μl of TSB. Then 1.0 ml of RNAprotect Bacteria Reagent 
(Qiagen, Valencia, CA) was added, samples were vortexed vigorously for 30 sec and 
incubated at room temp for 15 min. Cells were then pelleted by centrifugation at 5,000 x 
g for 10 min in a Microfuge 18 centrifuge (Beckman-Coulter, Brea, CA); supernatants 
were removed and pellets were stored at -80˚C. Once all samples had been collected, 
the cells were thawed for 10 min, resuspended in 900 µl of RLT buffer, and RNA was 
isolated using an RNeasy Mini RNA Purification Kit (Qiagen, Valencia, CA) as described 
previously (146).   
Quantitative real-time PCR was performed using cidA-, lrgA-, and sigA-specific 
primers listed in Table 2. Briefly, 500 ng of total RNA was converted to cDNA using the 
Quantitect Reverse Transcription Kit from Qiagen (Valencia, CA). The samples were 
then diluted 1:50 and the cidA, lrgA, and sigA cDNA products were amplified using 5.0 
µM cidA-rt, lrgA-rt, and sigA-rt primers (Table 2), respectively, with the LightCycler DNA 
Master SYBR Green I kit (Roche Applied Science, Indianapolis, IN), following the 
manufacturer’s instructions. Fold changes in cidA and lrgA transcript levels were 
calculated using the comparative CT method (165), normalizing to the amount of sigA 
transcripts present in the RNA samples. Results were recorded in triplicate, 
representative of three independent experiments.   
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Fluorescence-activated cell sorting flow cytometry of cells grown planktonically 
 To count the number of cells expressing nuc in planktonic cells cultures, S. 
aureus strains grown overnight were adjusted to an OD600 of 0.06 in 12.5 ml of TSB 
containing 0.25% glucose and grown for 4 hours with shaking at 250 rpm at 37°C using 
a 10:1 flask to volume ratio. After 4 hours of growth, 1000 µl of cells were washed with 
1x phosphate buffer saline (PBS) and then 200 µl of washed cells were pipetted into a 
clear 96-well plate and analyzed  on a BD LSRII flow cytometer (Beckton and Dickinson, 
San Jose, California). A total of 10,000 events from each cell culture sample were 
analyzed at a flow rate of 1000 cell per second. Bacteria were distinguished from 
background using forward and side scatter light using wild-type cells without a 
fluorescent reporter plasmid as a negative control. To enumerate sGFP positive cells, 
samples were excited at 488 nm using an argon laser and detected using a 530+30 nm 
(with a 505 nm long-pass filter). The raw data were then analyzed and plotted using 
FlowJo data analysis software (FlowJo, LLC, Ashland, OR).   
 
Biofilm assays 
BioFlux1000 biofilm assays to evaluate gene expression and biofilm morphologies 
To monitor gene expression and biofilm morphologies, S. aureus biofilm 
development was assessed using a BioFlux1000 microfluidic system (Fluxion 
Biosciences Inc., San Francisco, CA) as described previously (148). Using BioFlux1000 
48-well plates, the biofilm growth channels were primed by adding 200 µl of TSB to the 
output wells and initiating a reverse flow for 5 min at 5.0 dyn/cm2. To seed the channels 
with bacteria, excess TSB in the output wells was replaced with 200 µl of fresh overnight 
S. aureus cells diluted to an OD600 of 0.8 and pumped into the channels at 2.0 dyn/cm
2 
for 5 sec. Cells were then allowed to attach to the surface of the plate for 1 hour at 37°C. 
Remaining inocula was aspirated from the output well and 1.3 ml of 50% TSB was 
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added to the input wells and pumped at 0.6 dyn/cm2 for 18 hours (Figure 2-2 depicts 
macroscopic view of serpentine channels, output and input wells, and the center viewing 
area). Brightfield and epifluorescence images were acquired in 5-min intervals for a total 
of 217 time points. All epifluorescence images observing GFP and/or sDsRED 
expression were acquired using a fluorescein isothiocyanate (FITC) and 
Tetramethylrhodamine (TRITC) filters, respectively, and kept at constant acquisition 
settings (FITC; Gain: 20, Exposure: 500 ms and TRITC; Gain: 10, Exposure: 600ms). 
For a more detailed protocol of utilizing the BioFlux1000 to evaluate staphylococcal 
biofilm development, refer to reference (166).   
 To ensure nuclease was actively being made using the inducible aTet plasmid 
system (pRMC2 and pRMC2-nuc) under non-inducing conditions, wild-type and ∆nuc 
mutant strains containing pRMC2 or pRMC2-nuc supernatants from effluents of 3-h 
biofilms grown in the BioFlux without aTet were incubated with S. aureus genomic DNA 
overnight and separated in a 1% agarose gel. 
 
Determination of adding proteinase K, DNaseI, or PAS to biofilms grown in 
BioFlux1000 
 To determine the effects of proteinase K (Invitrogen Inc.), DNase I (Fermentas 
Inc.), or lysis-inhibitor polyanethole sulfonate (PAS) on biofilm development in the 
BioFlux1000, channel priming and cell seeding were performed as described above and 
1 ml of 50% TSB or 1 ml of 50% TSB supplemented with either 100 µg ml-1 of proteinase 
K, 0.5 units ml-1 of DNase I, or 50 µg/ml of PAS was pumped at 0.6 dyn/cm2 for eight 
hours. Where indicated, flow was stopped intermittently and 1 ml of 50% TSB was 
replaced with 1 ml of 50% TSB supplemented with proteinase K or DNase I. After 
restarting the flow, brightfield images were acquired in two-hour intervals. 
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Figure 2-1 Macroscopic view of a 48-well BioFlux plate  
Macroscopic view of input and output wells of a 48-well BioFlux plate with media in the 
center of wells. Circle in the center of wells is the viewing window of the microfluidic 
channels. To prime channels, 200 μl of TSB is pumped for 5 min from output to input 
wells. After excess TSB is aspirated from output, 200 μl of adjusted inoculums are 
seeded into the channels by pumping for 5 s from output to input wells. After 1 h 
incubation, biofilms are grown in 50 % TSB pumped from input to output wells for 18 h at 
0.6 dyn/cm 2 (64 μl/h). 
 
Figure modified from Derek E. Moormeier and Kenneth Bayles. 2013. Methods Mol Biol   
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Determination of adding exogenous DNA to biofilms grown in BioFlux1000 
 To determine the effects of adding exogenous DNA to S. aureus biofilms grown 
in BioFlux1000, an overnight culture of S. aureus wild-type UAMS-1 strain was adjusted 
to an OD600 of 0.8 in TSB containing 0.25% glucose and then seeded and into 
microchannels of BioFlux1000 plate as described above and allowed to adhere for 1 
hour at 37°C. Subsequently, an arbitrary amount of lyophilized salmon sperm DNA (1 µg 
ml-1) resuspended in 50% TSB buffered in MOPS at a pH 7.4 or 50% TSB buffered in 
MOPS at a 7.4 were  perfused over attached cells for 18 hours at a shear stress of 0.6 
dyn/cm2 and images were acquired in 5 minute intervals. The 6 hour time point of biofilm 
coverage was quantified as described below and plotted using GraphPad Prism.   
 
Quantification of acquired BioFlux biofilm images 
 Using BioFlux Montage software (Fluxion Biosciences Inc.), representative 
brightfield and epifluorescence images were selected and adjusted to similar brightness 
and calibrated to 0.323445 µm/pixel. For brightfield images, a threshold was set using 
the Threshold Tool and Slider tool to include all dark objects (biofilm cells) within each 
image. The total percent area of coverage of the dark objects was designated as percent 
biofilm coverage and plotted over time. For epifluorescence images, a threshold was set 
similar to that described above to cover all light objects (fluorescent cells) in each image. 
The total percent area of coverage was designated percent fluorescence coverage and 
plotted over time. All time points were plotted in either one hour or 15-min intervals using 
GraphPad Prism version 5.0 for Windows (GraphPad Software, La Jolla, CA). 
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Isolation of eDNA from BioFlux biofilms 
 S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) biofilms were 
grown with or without active DNase I (heat-inactivated 10 min at 95°C) for 4 hours in the 
BioFlux system in four identical channels as described above. In the output wells, 200 µl 
of 50 mM TES buffer (TRIS-HCl; pH 8.0, 10 mM EDTA, and 500 mM NaCl) containing 
10 µg ml-1 chloramphenicol and 50 µg ml-1 proteinase K were added to inhibit cell growth 
in the effluent. After 4 hours of biofilm growth, excess media and effluent were removed 
from the input and output wells, and the output wells were wiped clean with sterile cotton 
tipped applicators.  To extract biofilms from channels, 400 µl of 50 mM TES buffer 
containing 100 µg ml-1 proteinase K was added to the output wells and then pumped into 
the input wells for 10 minutes at 5.0 dyn/cm2 and 10 minutes at 20.0 dyn/cm2. After 
ensuring the biofilms had been completely removed from the channels, 350 µl of the flow 
through from the four replicate channels were pooled into pre-chilled tubes, centrifuged 
for 5 min at 14,000 rpm, and 1 ml of the supernatant was transferred to new tubes. 
Excess biofilm supernatants were discarded and pellets were resuspended in 1 ml of 
water and kept on ice until OD600 was determined. The eDNA from supernatants was 
extracted once with 1 ml of phenol:chloroform:isoamyl alcohol (25:24:1) and  once with 
900 µl of chloroform:isoamyl alcohol (24:1). To precipitate the eDNA, 500 µl of the 
aqueous phase was mixed with 50 µl of 3M potassium acetate (pH 5.0) and 1.5 ml of 
ice-cold 100% ethanol and then stored at -20°C overnight. The following day the 
precipitated DNA was collected by centrifugation (15,000 × g) for 20 min at 4°C, washed 
with ice-cold 75% (v/v) ethanol, air-dried at room temperature, and dissolved in 200 µl of 
TE buffer. To quantify the amount of eDNA present, qRT-PCR was performed on each 
sample in a LightCycler DNA Master SYBR Green I (Roche) using gyrase primer sets as 
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previously described (99), and the eDNA concentrations (ng µl-1) were normalized to 
total OD600 in 1 ml of water. 
 
Static biofilm assays 
To analyze expression in a static biofilm, overnight cultures of each strain were 
grown and diluted to an OD600 of 0.05 in TSB+0.5% glucose with 1.0 µM Toto-3. 
Subsequently, 400 µl of each inoculum was placed in one well of an 8-chamber Lab-Tek 
Chambered #1.0 Borosilicate Coverglass system (Nunc, Rochester, NY). Biofilms were 
grown for 6 hr at which point they were imaged using an inverted Zeiss 510 Meta 
Confocal Laser Scanning Microscope (CLSM) with an EC Plan-Neofluar 40x/1.30 na Oil 
DIC M27 objective. For each sample several z-stack images were acquired using 488 
nm excitation of GFP with 505-550 nm bandpass filter detection, as well as the 
acquisition of DIC images. Moreover, 3D reconstructions of the static biofilm images 
were completed using the Imaris 7.0.0 software suite (Bitplane, Saint Paul, MN). 
 
Statistical analysis 
Differences in eDNA present within the biofilms produced by different strains and 
under different experimental conditions were analyzed by performing a one-way ANOVA 
test with a Tukey post-test using GraphPad Prism (GraphPad Software, La Jolla, CA). 
Data for RNA quantification were analyzed using the Wilcoxon rank-sum test for non-
parametric data using GraphPad Prism (GraphPad Software, La Jolla, CA).   
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CHAPTER III:4 
The Control of Sae-Dependent Nuclease-Mediated Exodus during Early 
Staphylococcus aureus Biofilm Development 
 
INTRODUCTION 
 Biofilms are multicellular communities of bacteria aggregated by a self-produced 
extracellular matrix (ECM) comprised of proteins, carbohydrates, and extracellular DNA 
(eDNA) (76). In pathogenic bacteria, such as Staphylococcus aureus, the formation of 
biofilms within host tissues and on implanted medical devices leads to chronic infections 
due to their recalcitrance to antimicrobial therapies and host immune responses (167). 
Indeed, S. aureus is a leading cause of a variety of diseases ranging from skin and soft 
tissue infections, to more serious illnesses including endocarditis, necrotizing 
pneumonia, and osteomyelitis (63, 168, 169), and its ability to form biofilms is an 
important determinant of virulence in many of these infections (67). 
 S. aureus biofilm development has previously been described to occur in three 
successive steps: 1) attachment, 2) accumulation/maturation, and 3) 
detachment/dispersal (76). The initial attachment step has been shown to involve 
different surface factors including teichoic acids (88), potentially through surface charge 
interactions, and several different surface-associated proteins that allow the cells to 
adhere to either polymeric surfaces or host matrix components (170, 171). As the biofilm 
matures, synthesis of the ECM components allows the cells to mature into three-
dimensional structures (100, 148). Production of the self-produced proteases (33), 
                                                          
The majority of the work in CHAPTER III has been published in Moormeier DE, 
Bose JL, Horswill AH, and Bayles KW. 2014. mBio. 
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phenol-soluble modulins (PSMs) (117), and nucleases (100, 119) mediate ECM 
disruption and the switch from the biofilm lifestyle to planktonic growth.  Indeed, adding 
exogenous enzymes or peptides targeting various ECM components, including DNase I 
(eDNA), proteinase K (proteins), synthetic PSMs (proteins), and dispersin B 
(polysaccharide intercellular adhesion [PIA]) have been shown to cause biofilm 
disassembly (100, 111, 117, 172). 
 In the studies described in this chapter, we examined the early stages of biofilm 
development and assessed the matrix composition as the biofilm matured. 
Unexpectedly, we identified a distinct transition in matrix composition immediately prior 
to a previously unrecognized exodus of a subpopulation of the biofilm, which was 
initiated prior to the development of tower structures. In addition, we demonstrated that 
exodus was dependent on the coordinated, stochastic expression of the gene encoding 
the secreted staphylococcal nuclease regulated by Sae two-component system. 
Likewise, we also showed that the coordinated stochastic expression is not only limited 
to nuclease, but other Sae-regulated factors as well. Together, these findings suggest 
the existence of a complex regulatory strategy that controls matrix composition during 
the early stages of biofilm development, and provide novel insight into a nuclease-
mediated exodus of biofilm cells and the regulation of Sae-controlled factors. 
 
RESULTS 
Defining the early stages of S. aureus biofilm development  
Investigation of S. aureus UAMS-1 biofilm development using a BioFlux 
microfluidics system revealed that primary attachment of the S. aureus cells is followed 
by rapid multiplication into a confluent “lawn” (Figure 3-1A). At about the 6-hour time 
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point, an apparent exodus in a subpopulation of the biofilm was observed, followed by 
distinct foci of robust biofilm growth, resulting in tower formation.   
To further study these early events in biofilm development, we established a 
method to quantify the amount of biofilm coverage occurring over time (Figure 3-1B). To 
accomplish this, we set a threshold for dark objects (biofilm cells) within each brightfield 
image and measured the percent of the area that these objects covered. The data was 
then plotted as percent biofilm coverage versus time. As seen in Figure 3-1B, after the 
initial attachment of cells (0 h), there was a gradual increase in the biofilm coverage 
observed until about six hours, at which time the population began to contract until about 
11 hours. It was during this exodus stage (at approximately 8 h) that we observed the 
initial signs of tower development, which proceeded until the termination of the 
experiment at 18 hours. To delineate between previously used terminologies of biofilm 
formation, the terms, “multiplication” and “exodus”, were chosen to describe these 
previously uncharacterized stages of biofilm development (Figure 3-1). 
 
Protein-dependent attachment and multiplication 
 To characterize the early stages of biofilm development, the contributions of 
different ECM components to S. aureus biofilm attachment and multiplication were 
examined using the BioFlux system. Unlike other S. aureus strains that produce biofilms 
with a PIA-based matrix (92, 95), biofilms produced by both S. aureus UAMS-1 and 
USA300 LAC strains have been reported to be PIA-independent (113, 173). In 
agreement with this, we observed no difference in early biofilm formation with UAMS-1 
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Figure 3-1 Early stages of S. aureus biofilm development 
 
S. aureus UAMS-1 (wild-type) biofilms were grown in a BioFlux microfluidics system, 
and bright-field images were captured throughout an 18-h time course experiment. (A) 
Representative images at the indicated time points of a typical UAMS-1 S. aureus biofilm 
depicting four stages of development: attachment (stage 1), multiplication (stage 2), 
exodus (stage 3), and biofilm maturation (stage 4). Attachment of cells to the glass 
bottom plate is quickly followed by the multiplication of the cell population into a 
confluent “lawn.” An exodus event after multiplication is followed by robust tower 
formation. Scale bar, 50 µm. (B) Quantification of typical S. aureus biofilm development 
presented as a percentage of biofilm coverage plotted versus time. Labels indicate the 
duration during which each biofilm stage is occurring. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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or JE2 (a USA300 LAC derivative) (Figure 3-2) mutants in which the genes encoding the 
PIA biosynthesis machinery have been disrupted.  
In previous studies, we reported that eDNA is an important matrix component in 
S. aureus biofilm development and that modulation of the eDNA matrix has a dramatic 
effect on biofilm maturation (99, 100, 119, 174), including during the initial stages of 
development in a static assay (22). To gain a better understanding of the contribution of 
eDNA during early biofilm development under the flow cell conditions used in the current 
study, we added exogenous DNase I (0.5 Units ml-1) at various time points (2-h intervals) 
during the biofilm attachment and multiplication phases. Similar to a recent study 
demonstrating DNase I insensitivity during early biofilm development (175), the addition 
of DNase I had no effect on the biofilm through eight hours of growth (Figure 3-3A), 
suggesting that the initial attachment and multiplication stages lack eDNA under these 
conditions or that the eDNA present in the matrix during this time is insensitive to DNase 
I treatment.     
S. aureus produces a number of surface-associated and secreted proteins 
important for adherence. Considering the findings that the attachment and multiplication 
stages are DNase I insensitive (Figure 3-2A), we hypothesized that proteins may play a 
critical role in these early biofilm formation events. In agreement with this, the 
staphopain proteases have recently been shown to modulate S. aureus biofilm integrity 
(33). To test the role of proteins, we performed a similar experiment as above except 
adding proteinase K (100 µg ml-1) at 2-h intervals. As shown in Figure 3-2B, the addition 
of proteinase K detached the entire biofilm at every time point tested. Taken together 
with the DNase I data, these results indicate that the attachment and multiplication 
stages are dependent on protein components produced by the bacteria.  
In an attempt to identify specific proteins important in the attachment and 
multiplication stages, we utilized the BioFlux system to screen the Nebraska Transposon 
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Figure 3-2 Effects of exogenous proteinase K and DNase I on biofilm attachment 
and multiplication 
 
S. aureus wild-type (UAMS-1) biofilms were grown in the BioFlux system with (open 
circles) or without (closed circles) exogenously added (A) DNase I (0.5 U ml−1) or (B) 
proteinase K (100 µg ml−1) at 0, 2, 4, and 6 h after the initiation of the experiment. 
Arrows in graphs indicate time points at which either proteinase K or DNase I was added 
to developing biofilm. Each graph shows the mean percentage of biofilm coverage in 2-h 
intervals. The data represent the means from two independent experiments, each 
containing at least two technical replicates. Error bars show the standard errors of the 
means (176) from the two independent experiments. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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Mutant Library (NTML) (155) for mutants that are defective in the production of 
MSCRAMM proteins, including fibronectin-binding proteins A and B (FnbA and FnbB) 
(78), Empbp (177), clumping factors A and B (ClfA and ClfB) (81, 82), Protein A  (178), 
elastin-binding protein (EbpS) (179), Sas family proteins (180, 181), and serine-
aspartate repeat (Sdr) family proteins (79, 80). In addition, we examined a srtA mutant, 
which is defective in the processing of several LPXTG-motif containing MSCRAMM 
proteins into the cell wall (182). However, none of these mutants exhibited observable 
changes in biofilm development when grown in the BioFlux system (Table 3). We also 
selected mutants defective in the production of secreted proteins such as the as α- and 
β-hemolysins, which have been previously shown to play a role in biofilm development 
(108, 183) (Table 3). Again, no noticeable differences in biofilm formation were 
observed. Finally, we also tested an atlA mutant, in which the primary autolysin is 
disrupted, for early biofilm defects. Consistent with previous findings (104), we saw 
limited cell attachment and no biofilm multiplication (Figure 3-3) using this strain, 
suggesting its role in these early stages of biofilm formation. In addition, we added PAS, 
an autolysis inhibitor, in two hour time points to developing UAMS-1 wild-type biofilms in 
the BioFlux100 and saw abolishment of the biofilm development (Figure 3-4). Overall, 
these results support a role for Atl in biofilm attachment and/or multiplication, but fail to 
identify a role for other cell surface and secreted proteins in these processes, although 
the requirement for a combination of proteins cannot be ruled out.  
 
Exodus is mediated by staphylococcal nuclease 
Quorum sensing is the coordinated expression of genes in response to cell 
density. In S. aureus, it is accomplished through the Agr system, which contributes to 
biofilm dispersal after tower development through activation of proteases and PSMs 
(111, 117). Thus, we hypothesized that this exodus stage is also controlled by the Agr 
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Table 3. NTML mutants screened for involvement in early biofilm development 
 
NTML 
a
NE # 
S. aureus 
USA300_FPR3757 
Locus 
 
b
Gene 
Name 
 
 
c
Putative Protein 
 
d
Biofilm 
Phenotype 
NE186 SAUSA300_2441 fnbA Fibronectin binding protein A + 
NE728 SAUSA300_2440 fnbB Fibronectin binding protein B + 
NE543 SAUSA300_0772 clfA Clumping factor A + 
NE391 SAUSA300_2565 clfB Clumping factor B + 
NE1558 SAUSA300_0774 empbp Secretory extracellular matrix 
and plasma binding protein 
+ 
NE1561 SAUSA300_1370 ebps Cell surface elastin binding 
protein 
+ 
NE286 SAUSA300_0113 (spa) Immunoglobulin G binding 
protein A precursor 
+ 
NE56 SAUSA300_1702 (sasC) Cell wall surface anchor family 
protein 
+ 
NE825 SAUSA300_2436 (sasG) Putative cell wall surface anchor 
family protein 
+ 
NE33 SAUSA300_2589 - LPXTG-motif cell wall surface 
anchor family protein 
+ 
NE851 SAUSA300_0883 - Putative surface protein + 
NE1 SAUSA300_1327 - Cell surface protein + 
NE1787 SAUSA300_2467 srtA Sortase A + 
NE1363 SAUSA300_1034 srtB Sortase B + 
NE460 SAUSA300_0955 atlA Autolysin - 
NE37 SAUSA300_2600 icaA N-glycosyltransferase + 
NE1167 SAUSA300_2601 icaB Intercellular adhesion protein B + 
NE766 SAUSA300_2602 icaC Intercellular adhesion protein C + 
NE302 SAUSA300_0152 cap5A Capsular polysaccharide 
biosynthesis protein Cap5A 
+ 
NE1235 SAUSA300_0156 cap5E Capsular polysaccharide 
biosynthesis protein Cap5E 
+ 
NE1286 SAUSA300_2598 cap1A Capsular polysaccharide 
biosynthesis protein Cap1A 
+ 
NE67 SAUSA300_2573 isaB Immunodominant antigen B + 
NE1746 SAUSA300_2088 luxS S-ribosylhomocysteinase + 
NE1354 SAUSA300_1058 (hla) Alpha-hemolysin + 
NE1261 SAUSA300_1973 (hlb) Truncated-beta hemolysin + 
Colors indicate functional group: red, LPXTG-motif surface proteins; green, LPXTG-motif protein processing; grey, 
autolysin; blue, extracellular polysaccharide biosynthesis; orange, other secreted and surface proteins 
a  NE# are obtained from Nebraska Transposon Mutant Library (NTML) website (http://app1.unmc.edu/fgx/) 
b Gene names are from NTML website.  (gene name) indicates gene that is not annotated in the USA300_FPR3757 
genome, but replaced with a gene name annotation from other S. aureus genomes with similar gene identity. – indicates 
a putative/hypothetical protein not yet annotated. 
c Putative proteins as described on NTML website. 
d  + indicates no changes in early S. aureus biofilm development (0-8hr) compared to JE2 wild-type. – indicates early S. 
aureus biofilms defective in either biofilm attachment or accumulation (0-8 hr). 
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Figure 3-3 Effect of USA300 JE2 atlA mutant on early biofilm formation 
 
The S. aureus wild-type (USA300 LAC JE2) and atlA::ΦΝΣ mutant derivative strains 
were grown in the BioFlux system. Bright-field microscopic images were acquired in 5-
min intervals at ×200 magnification. Images at 1 h, 3h, and 6 h are representative of 
multiple experiments. Note the clumping in the atlA::ΦΝΣ mutant and the lack of biofilm 
at 6 h. Scale bar, 50 µm. 
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Figure 3-4 Addition of PAS to UAMS-1 wild-type biofilms inhibits proper biofilm 
development 
 
S. aureus wild-type (UAMS-1) biofilms were grown in the BioFlux system with (184) or 
without (blue) exogenously added PAS (500 µg ml-1) at 0, 2, 4, and 6 h after the initiation 
of the experiment. Arrows in graphs indicate time points at which PAS was added to 
developing biofilm. Each graph shows the mean percentage of biofilm coverage in 2-h 
intervals. The data represent the means from two independent experiments, each 
containing at least two technical replicates. Error bars show the standard errors of the 
means (176) from the two independent experiments. 
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quorum-sensing system. To test this, we obtained an agr::tet mutant (UAMS-155) 
derivative of UAMS-1 and observed its ability to form a biofilm as described above. 
Interestingly, although the agr::tet mutant exhibited increased initial attachment and 
biofilm multiplication, exodus of a subpopulation was still clearly evident (Figure 3-5), 
indicating that this event is largely independent of the Agr system. These results were 
not specific to this strain as an agrA::ΦΝΣ transposon mutant of JE2 displayed a similar 
pattern of exodus during this time period (Figure 3-6). Since previous studies have 
demonstrated that the Agr P3 promoter is activated in a subpopulation of cells in S. 
aureus biofilms (110, 117), we also tested a GFP reporter that was driven by the Agr-
dependent P3 promoter. Consistent with the lack of involvement of agr in this exodus 
event, no P3 promoter activity was detected in the UAMS-1 strain until 13 hours of 
biofilm growth, where expression was primarily limited to the towers (Figure 3-7) as 
previously observed (110). Collectively, these findings indicate that the exodus of the 
biofilm population observed in these assays are independent of the Agr quorum-sensing 
system, and that this event is distinct from the previously described Agr-dependent 
dispersal of cells that occurs after tower formation. 
S. aureus synthesizes a myriad of extracellular proteins, the stability and 
processing of which are modulated by ten secreted proteases (34). Our observation that 
proteinase K disrupted biofilms suggests that S. aureus secreted proteases may play a 
role in the biofilm exodus event. Indeed, recent studies have demonstrated that the 
staphopain proteases can modulate biofilm integrity (33). However, a USA300 LAC 
derivative deficient in all ten secreted proteases (AH1919) (156) showed no defects in 
exodus of the biofilm subpopulation when compared to its parental strain (AH1263) 
(Figure 3-8), suggesting that this event is independent of these proteases. In this regard, 
several reports have demonstrated that deletion of the secreted nuclease (Nuc) in S. 
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Figure 3-5 Effect of UAMS-1 agr and icaA mutations on early biofilm development 
 
The S. aureus agr  and icaA mutant strain, UAMS-155 (agr::tet) and KB8037 (icaA:: 
ΦΝΣ, respectively, were inoculated in parallel with UAMS-1 (wild type) in the BioFlux 
system and allowed to form a biofilm for 18 h (A) Images selected at 4 h and 8 h are 
representative of wild-type (185) and agr::tet biofilms from multiple experiments. Scale 
bar, 50 µm. (B) The graph depicts the percentage of biofilm coverage in 15-min intervals 
of wild-type (185), agr::tet, and icaA:: ΦΝΣ mutants biofilms over 8 h of growth. The data 
represent the means from two independent experiments, each containing three technical 
replicates. Error bars show the SEM from the two independent experiments. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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Figure 3-6 Early biofilm development in the S. aureus USA300 LAC JE2 strain with 
agrA, nuc, and, icaA mutant derivatives 
 
The S. aureus wild-type (USA300 LAC JE2), agrA::ΦΝΣ, nuc::ΦΝΣ, and icaA::ΦΝΣ 
mutant derivatives were grown in the BioFlux system. Bright-field microscopic images 
were acquired in 5-min intervals at ×200 magnification. Images at 4 h and 8 h are 
representative of multiple experiments. Scale bar, 50 µm. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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Figure 3-7 Expression of Agr-dependent P3 promoter fusion in biofilm formation  
 
UAMS-1 wild-type S. aureus cells containing the Agr P3::gfp reporter (pKH4) plasmid 
were inoculated into a BioFlux microfluidic system and allowed to form a biofilm within a 
flow shear environment at a flow rate of 64 μl/h for a total of 18 h. Bright-field and 
epifluorescence microscopic images were collected at 5-min intervals at ×200 
magnification. The images presented were taken from the complete set of 217 images 
spanning 0 to 11 h and illustrate typical tower development and GFP expression 
observed in multiple experiments. Note the lack of P3 expression during early biofilm 
development (<11 h), and the P3 induction in the large tower. The scale bar represents 
50 μm. 
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Figure 3-8 Effect of ten major secreted proteases on early biofilms 
 
The S. aureus wild-type strain (AH1263) and a mutant derivative lacking all 10 major 
secreted proteases (AH1919) were grown in the BioFlux system. Bright-field microscopic 
images were acquired in 5-min intervals at ×200 magnification. Images at 4 h and 8 h 
are representative of three independent experiments with at least two technical 
replicates. Scale bar, 50 µm. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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aureus causes an increase in biofilm formation as a result of decreased eDNA 
degradation in the biofilm ECM (100, 119, 122). Based on this, we hypothesized that 
exodus of the biofilm population is mediated by the function of staphylococcal nuclease 
in the degradation of eDNA. To test this, we cultured biofilms produced by the wild-type 
(UAMS-1) and Δnuc mutant (UAMS-1471) strains harboring a ‘leaky’ anhydrotetracycline 
(aTet)-inducible expression vector (pRMC2-nuc) driving low-level nuc transcription, and 
then quantified the coverage of the developing biofilm as described above. In support of 
a role for nuclease in the exodus event, the Δnuc mutant containing the empty vector 
(pRMC2) failed to initiate exodus, which resulted in considerably thicker biofilms 
compared to the wild-type harboring either pRMC2 or pRMC2-nuc (Figure 3-9A). 
Quantification of the biofilm over the first eight hours showed considerably more biofilm 
present past six hours of growth in the ∆nuc mutant containing pRMC2 and a reversion 
to wild-type levels of exodus when grown with pRMC2-nuc (Figure 3-9B). To determine if 
this phenomenon was conserved in another S. aureus strain, we also grew wild-type JE2 
and its nuc mutant derivative (nuc::ΦΝΣ) biofilms in parallel. Like the UAMS-1 strain, the 
nuc::ΦΝΣ mutant demonstrated biofilm growth that lacked the exodus event, 
accumulating to a higher cell density over time compared to the wild-type JE2 strain 
(Figure 3-6). Together, these data demonstrate that the S. aureus secreted nuclease 
plays a major role in the exodus of the biofilm population prior to tower formation and 
suggests nuclease insensitivity before the exodus event occurs. 
 To determine if the exodus defect in the Δnuc mutant could be restored by the 
addition of exogenous nuclease, we grew wild-type, Δnuc mutant, and nuc complement 
biofilms with or without media supplemented with DNase I (0.5 Units ml-1) starting at the 
0-h time point. As shown in Figure 3-10, the addition of DNase I had little effect on 
biofilm multiplication or exodus in the wild-type strain. In contrast, the presence of 
DNase I caused exodus of the Δnuc mutant biofilm, but not until approximately six hours 
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Figure 3-9 Exodus requires staphylococcal nuclease 
 
Biofilms of the S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) containing 
pRMC2 or pRMC2-nuc were grown in the BioFlux system. (A) Selected bright-field 
images at 4 h and 8 h are representative of bioflims of the wild-type (UAMS-1) or Δnuc 
mutant (UAMS-1471) containing pRMC2 or pRMC2-nuc from multiple experiments. 
Scale bar, 50 µm. (B) The graph shows the mean percentage of biofilm coverage in 15-
min intervals of biofilms of the wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) 
containing pRMC2 or pRMC2-nuc over 8 h of growth. The data represent the means 
from two independent experiments, each containing at least three technical replicates. 
Error bars show the SEM from the two independent experiments. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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Figure 3-10 Functional complementation of the nuc mutant biofilm phenotype by 
addition of DNase I 
 
S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) cells were grown in the 
BioFlux with or without DNase I (0.5 U ml−1). The graph shows the mean percentage of 
biofilm coverage in 15-min intervals of wild-type (185) and Δnuc biofilms grown in the 
presence or absence of DNase I. The data represent the means from two independent 
experiments, each containing three technical replicates. Error bars show the SEM from 
the two independent experiments. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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of biofilm development when the exodus event is normally observed (Figure 3-10). To 
assess whether nuclease insensitivity prior to six hours was a result of the absence of 
eDNA in the matrix during this time, we isolated eDNA at four hours from wild-type 
(UAMS-1) and ∆nuc mutant (UAMS-1471) biofilms grown in the absence or presence of 
active DNase I (0.5 Units ml-1). Although eDNA is clearly detectable during the 
multiplication stage and there is a trend toward differences in the levels of eDNA present 
between the DNase I treated and untreated biofilms, both wild-type and ∆nuc mutant 
biofilms cultured with and without DNase I showed no significant differences in eDNA 
levels (Figure 3-11) suggesting that there is some protection from the activity of this 
nuclease by other components of the biofilm matrix.   
 
Biofilm exodus is preceded by nuclease expression 
 The data generated so far demonstrates that biofilm exodus is reproducibly 
initiated in a nuclease-dependent manner at approximately six hours after the initiation of 
biofilm development. Based on these results, we hypothesized that nuc expression 
would precede biofilm exodus at approximately six hours. To test this, the UAMS-1 and 
JE2 strains containing a previously constructed nuc::gfp promoter fusion plasmid 
(pCM20) were studied to determine the temporal expression of nuc during biofilm 
development. As anticipated, nuc expression was induced just prior to the exodus event 
at six hours, albeit in only a subpopulation (<1%) of the cells (Figure 3-12). To quantify 
the induction of nuc expression, we set a threshold that would enumerate all of the light 
objects (fluorescent cells) in each image and plotted this as percent fluorescence 
coverage over time. As seen in Figure 3-13, nuc expression was initially observed at 
three hours and maximally expressed near five hours of biofilm growth, preceding biofilm  
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Figure 3-11 Quantification of eDNA isolated from BioFlux biofilms 
 
S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) biofilms were grown with 
or without active DNase I (heat-inactivated 10 min at 95°C) for 4 hours in the BioFlux 
system in four identical channels. After 4 hours of biofilm growth, eDNA was isolated as 
described in Materials and Methods. The data represent the means from two 
independent experiments, each containing three technical replicates. Error bars show 
the SEM from the two independent experiments. 
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Figure 3-12 Expression of nuc precedes exodus of a biofilm subpopulation 
 
S. aureus wild-type UAMS-1 and JE2 cells containing the nuc::gfp reporter plasmid 
(pCM20) were grown in the BioFlux system. Bright-field and epifluorescence microscopic 
images were acquired in 5-min intervals at ×200 magnification. (A) Bright-field and 
epifluorescence (GFP) images at 2 h and 5 h are representative of multiple experiments 
of UAMS-1 pCM20. Scale bar, 20 µm. (B) The plot depicts biofilm growth as the mean 
percentage of UAMS-1 pCM20 biofilm coverage and the nuc-expressing cells as the 
mean fluorescence coverage in 15-min intervals over 8 h of growth. The data represent 
the means from two independent experiments, each containing at least two technical 
replicates. Error bars were omitted for clarity. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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exodus. These results indicate that both temporal and stochastic regulatory mechanisms 
control nuc promoter activity during biofilm development. 
The Sae two-component regulatory system controls nuc-mediated exodus 
Previous results have shown that the Sae two-component system regulates 
nuclease expression (48). Hence, to gain insight into the regulation of the exodus event, 
we tested wild-type AH1263 (USA300 LAC derivative) and its saeQRS::spc mutant 
(AH1558) for biofilm development and nuc expression. Consistent with its role as a 
positive regulator of secreted nuclease, the saeQRS::spc mutant biofilm developed in a 
way that was similar to a nuc mutant, lacking biofilm exodus and accumulating to a high 
cell density (Figure 3-13). However, the saeQRS::spc mutant also exhibited an apparent 
decrease in the rate of biofilm multiplication suggesting a role for this regulator in the 
production of some factor(s) important in this process. Additionally, the saeQRS::spc 
mutant demonstrated much reduced nuc expression compared to wild-type AH1263 
(Figure 3-13), indicating that the temporal and/or stochastic control of nuc expression 
requires the Sae regulatory system. 
To continue to dissect the function that the Sae system has in regulating nuc 
expression and biofilm development, we obtained clean deletion mutations in saeP, 
saeQ, saeS, and saePQRS in the AH1263 strain background and moved the Pnuc::gfp 
(pCM20) fluorescent reporter fusion into these genetic backgrounds. To determine if 
these mutations had any effect on growth, we grew them aerobically for 24 hours in TSB 
containing 0.25% glucose. Under these growth conditions, we saw no major growth 
defect demonstrating that these mutations do not have a direct function in regulating 
expression of genes involved in growth (Figure 3-14).  To investigate the effects of the 
sae mutations on biofilm and nuc expression, we cultivated these sae mutants 
containing pCM20 in the BioFlux1000 to allow for biofilm formation.  
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Figure 3-13 Nuclease-mediated exodus is regulated by Sae 
 
S. aureus wild-type (AH1263) and saeQRS::spc mutant (AH1558) strains carrying 
the nuc::gfp reporter plasmid (pCM20) were grown in the BioFlux system. Bright-field 
and epifluorescence (GFP) microscopic images were acquired in 5-min intervals at ×200 
magnification. Images at 2, 5, and 8 h are representative images from two independent 
experiments. Scale bar, 50 µm. The plot depicts biofilm growth as the mean percentage 
of biofilm coverage and the nuc-expressing cells as the mean fluorescence coverage in 
15-min intervals over 8 h of growth. The data represent the means from two independent 
experiments, each containing at least two technical replicates. Error bars were omitted 
for clarity. 
 
Figure modified from Moormeier et al. 2014. mBio. 
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Figure 3-14 Growth analysis of sae mutants containing pCM20 grown 
planktonically 
 
S. aureus AH1263 (185) and sae mutants containing Pnuc::gfp reporter fusion (pCM20) 
were grown planktonically to determine effect on growth. Cultures were grown for 24 
hours with shaking at 250 rpm at 37°C using a 10:1 flask to volume ratio. Subsequently, 
supernatants were taken at 0, 3, 6, 9, 12 and 24 hours and the OD600 were measured 
and plotted over time. Data represents two independent experiments performed in 
duplicate. 
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Similar to the sae::spc mutant described before (Figure 3-13), we saw little to no nuc 
expression and an abrogated exodus stage in the ∆saeS and ∆saePQRS mutants 
(Figure 3-15). In addition, the ∆saeQ mutant showed an intermediate phenotype in nuc 
expression when compared to AH1263 and the ∆saeP strain (Figure 3-15). Interestingly, 
however, the ∆saeP mutant had an unusual phenotype. While there was little to no nuc 
expression during the first hours of biofilm development in a ∆saeP mutant biofilm, at 
around 3-3.5 hours, instead of only a subpopulation of nuc expressing cells like in 
AH1263 biofilm (Figure 3-13), the entire cell population expressed nuc (Figure 3-15). 
Interestingly, although the entire cell population is expressing nuc, there was no effect 
on the exodus stage itself (Figure 3-15). To determine if stochastic expression is 
observed in planktonic cells, we grew AH1263 and the sae mutant derivatives containing 
the Pnuc::gfp fluorescent reporter fusions for 3 hours in shaking flasks and then 
performed fluorescence-activated cell sorting (FACS). Unlike the subpopulations of cells 
expressing nuc in the parental and ∆saeQ strains during biofilm development, this effect 
is lost during planktonic growth. Indeed, >98% of the cells are expressing nuc in all of 
the strains except for the ∆saeS and ∆saePQRS mutants, which showed very little nuc-
gfp positive cells (Figure 3-16). These results suggest that the stochastic expression of 
nuc is a biofilm-specific phenotype not seen in planktonically growing cells. Collectively, 
these data further demonstrate that the Sae system regulates the exodus stage of 
biofilm development in a much more complex way than previously thought. 
Several different stimuli have been shown to affect the induction of the Sae 
system including SDS, H2O2, low pH, and sub-inhibitory concentrations of antibiotics and 
α-defensin (HNP-1) (157, 186-189), yet, the exact molecular mechanism in which the 
Sae system is activated is not known.  
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Figure 3-15 Effect of Sae mutations on nuc expression and early biofilm 
development 
 
S. aureus wild-type AH1263, ∆saeP, ∆saeQ, ∆saeS, and ∆saePQRS mutant derivative 
strains carrying the nuc::gfp reporter plasmid (pCM20) were grown in the BioFlux 
system. Bright-field and epifluorescence (GFP) microscopic images were acquired in 5-
min intervals at ×200 magnification. Images at 2, 5, and 8 h are representative images 
from two independent experiments. Scale bar, 50 µm.  
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Figure 3-16 FACS analysis of nuc expressing cells grown planktonically 
 
S. aureus AH1263 (185) and sae mutants containing Pnuc::gfp reporter fusion (pCM20) 
were grown planktonically for 4 hours with shaking at 250 rpm at 37°C using a 10:1 flask 
to volume ratio. Cells were then washed with 1x PBS and 10,000 events of each culture 
sample were counted using fluorescence-activated cell sorting (FACS) to determine 
number of GFP-positive cells. Data was plotted using FlowJo software and is 
representative of three biological replicates. 
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Additionally, most of these stimuli are not found in our in vitro biofilm conditions. Hence, 
we wanted to continue to evaluate how the Sae system is activated in S. aureus biofilms.  
Effect of exogenous DNA on planktonic S. aureus cells 
Initial data generated from the Horswill laboratory demonstrates that the 
extracellular lipoprotein SaeP binds eDNA (unpublished data from Horswill lab). Given 
that the Sae system controls nuclease which degrades eDNA within a biofilm, we 
hypothesized that eDNA may be the signal that the Sae system is sensing to control 
expression of nuclease. Therefore, we added exogenous salmon sperm DNA to a wild-
type strain containing the Pnuc-gfp reporter fusion biofilms grown in the BioFlux1000 to 
see if it would have an effect on nuc expression. To our surprise, the exogenously added 
DNA essentially wiped out the biofilms (Figure 3-17) making it impossible to evaluate its 
effect on nuc expression and suggesting that the additional DNA has an inhibitory effect 
on S. aureus biofilm development. Due to the inhibitory effect of exogenous DNA on S. 
aureus biofilm development, we decided to evaluate the influence that exogenous DNA 
may have on nuc expression in planktonic cells. Thus, we added increasing percentages 
(w/v) of salmon sperm DNA to planktonically growing wild-type cells containing the 
Pnuc::gfp reporter fusion. Surprisingly, we saw an indirect relationship between 
increasing amounts of DNA and decreasing amounts of nuclease expression at 3 hours 
of growth (Figure 3-18). However, at six hours of growth, the effect of added DNA on nuc 
expression was not as strong (Figure 3-19). Interestingly, we also saw that the addition 
of the 2% DNA caused a slight growth defect in wild-type cells (data not shown). Hence, 
when we sought to determine if a ∆saeP mutant would abrogate the effect of adding 
exogenous DNA seen in wild-type cells, we excluded 2% DNA in further analyses.  
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Figure 3-17 Effect of exogenous DNA on biofilm development 
 
S. aureus wild-type (UAMS-1) cells were grown in the BioFlux with or without salmon 
sperm DNA (1 µg ml−1). The graph shows the mean percentage of biofilm coverage in at 
six of UAMS-1 wild-type (185) biofilms grown in the presence or absence of DNA. The 
data represent the means from two independent experiments, each containing at least 
two technical replicates. Error bars show the SEM from the two independent 
experiments. 
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Figure 3-18 Effect of exogenous DNA on nuc expression in planktonic AH1263 
wild-type cells 
 
AH1263 wild-type and ∆saePQRS strains containing Pnuc::gfp reporter fusion (pCM20) 
were grown for 3 or 6 hours in TSB containing 0.25% glucose buffered in 50 mM 3-(N-
morpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different percentages 
of exogenous salmon sperm DNA. Fluorescence (nuc expression) was quantified using 
a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of 490 nm and 
emission wavelength of 525 nm. Relative fluorescence was determined by normalizing 
the quantified fluorescence per OD600 and plotted using GraphPad Prism. Data 
represents the averages from two independent experiments performed in duplicate. 
Error bars show the SEM from the two independent experiments. 
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Figure 3-19 Effect of exogenous DNA on nuc expression in planktonic ∆saeP cells  
AH1263 wild-type (184) and ∆saeP (blue) strains containing Pnuc::gfp reporter fusion 
(pCM20) were grown for 3 or 6 hours in TSB containing 0.25% glucose buffered in 50 
mM 3-(N-morpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different 
percentages of exogenous salmon sperm DNA. Fluorescence (nuc expression) was 
quantified using a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of 
490 nm and emission wavelength of 525 nm. Relative fluorescence was determined by 
normalizing the quantified fluorescence per OD600 and plotted using GraphPad Prism. 
Data represents the averages from two independent experiments performed in duplicate. 
Error bars show the SEM from the two independent experiments. 
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Remarkably, there were little differences seen between the wild-type and the ∆saeP 
mutant at both three and six hours (Figure 3-20) suggesting that the SaeP protein may 
not be the sole contributor to the decrease in nuclease expression in the presence of 
added DNA, at least under these planktonic conditions.  
Given the data that shows a decrease in nuc expression in response to 
increasing amounts of DNA, we also sought to determine if there were any effects on 
overall S. aureus growth in both wild-type, ∆saeP, and ∆saePQRS strains. Therefore, we 
grew these strains in the presence of increasing amounts of DNA and plotted the OD600 
over time. Interestingly in the AH1264 wild-type strain, increased amounts of DNA 
resulted in larger growth yields at 6-12 hours, yet, there were no differences at 24 hours 
(Figure 3-20; top color row panels). However, there were no difference between wild-
type and the ∆saeP and ∆saePQRS strains at various percentages of DNA (Figure 3-20; 
bottom black row panels). This suggests that S. aureus may be able to utilize extra DNA 
as an additional carbon source to cause increases in growth yield or perhaps a reduction 
in autolysis, though, this ability appears to be independent of the Sae system.  
 
Other Sae-controlled factors demonstrate stochastic expression similar to 
nuclease 
 Since the Sae system controls a myriad of other factors, and nuclease is 
stochastically expressed within a biofilm, we hypothesized that other Sae-controlled 
factors may be regulated similarly within a biofilm. To test this hypothesis, we obtained 
hla (α-toxin), hlgA (γ-toxin), and P1sae fluorescent reporter fusions in AH1263 wild-type 
and sae mutant strains and cultivated biofilms in the BioFlux1000.  
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Figure 3-20 Effect of exogenous DNA on planktonic growth 
 
AH1263 wild-type, ∆saeP, and ∆saePQRA strains containing Pnuc::gfp reporter fusion 
(pCM20) were grown for 24 hours in TSB containing 0.25% glucose buffered in 50 mM 
3-(N-morpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different 
percentages of exogenous salmon sperm DNA. OD600 were taken at 0, 1, 2, 3, 4, 5, 6 7, 
8, 9, 10, 11, 12, and 24 hours and plotted over time using GraphPad prism. Data 
represents the averages from two independent experiments performed in single flasks. 
Error bars show the SEM from the two independent experiments. Top row panels 
(colored) show relation of different percentages of DNA in one strain of S. aureus. 
Bottom two row panels (black) show relation of wild-type and sae mutants when grown 
with a certain percentage of exogenous DNA.  
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Figure 3-21 Expression of Sae-regulated genes hla, P1sae, and hlgA during biofilm 
development 
 
S. aureus wild-type AH1263 (185) strain and the ∆saeS mutant derivative strain carrying 
the Phla::gfp (pCM27), PhlgA::gfp (pCM11hlgA), and P1sae::gfp (pcm11P1sae) reporter 
plasmids were grown in the BioFlux system. Brightfield and epifluorescence (GFP) 
microscopic images were acquired in 5-min intervals at ×200 magnification. Images are 
at 5 h and are representative images from two independent experiments at least in 
triplicate. Scale bar, 50 µm.  
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Strikingly, in support of our hypothesis, the hla and P1sae reporter fusions demonstrated 
Sae-dependent stochastic expression (Figure 3-21) similar to nuc (Figures 3-12, 3-13, 3-
15). In contrast, the hlgA reporter showed no expression under our biofilm conditions 
(Figure 3-21). This is not completely unexpected given the recent results suggesting that 
hlgA is part of the Sae regulon that requires activation by external host signals (157).  
 Given that the hla and P1sae reporters demonstrated similar expression to nuc in 
a developing biofilm, we sought to characterize whether or not cells expressing nuc were 
also expressing other Sae-regulated genes. Thus, we generated a dual fluorescent 
reporter plasmid (pDM19) containing the promoter regions of nuc and coa 
(staphylocoagulase) and transduced it into AH1263 and sae mutants to simultaneously 
evaluate expression of two Sae-controlled genes during biofilm development. 
Remarkably, coa and nuc demonstrated identical stochastic expression patterns with 
only a subpopulation of cells expressing the fluorescent reporters in AH1263 wild-type 
strain (Figure 3-22). Additionally, much like the nuc expression studies described above, 
both the coa and nuc reporters were expressed in nearly every cell in the ∆saeP mutant 
biofilm. Also, little to no expression of either reporter was observed in the ∆saePQRS 
mutant (Figure 3-22). Altogether, these data suggest that the Sae system coordinates 
the expression of some Sae-regulated factors in a way that only initiates expression in a 
subpopulation of cells.  
DISCUSSION 
Our current understanding of S. aureus biofilm development is based on the 
characterization of three basic steps: 1) attachment, 2) accumulation/maturation, and 3) 
detachment/dispersal (76). The complexity of these processes was first highlighted in a 
study by Yarwood et al. (110) who used time-lapse video microscopy to visualize waves 
of growth and detachment that appeared to coincide with agr expression. More recent 
studies have revealed that detachment is largely dependent on expression of surfactant- 
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Figure 3-22 coa and nuc are expressed in the same subpopulation during biofilm 
development  
 
S. aureus wild-type AH1263 (185), ∆saeP, and ∆saePQRS mutant derivative strains 
carrying the Pnuc::gfp Pcoa::sdred dual reporter plasmid (pDM19) were grown in the 
BioFlux system. Brightfield and epifluorescence (GFP and sDsRed) microscopic images 
were acquired in 5-min intervals at ×200 magnification. Images are at 5 h and are 
representative images from two independent experiments at least in duplicate. Scale 
bar, 50 µm.  
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like molecules known as phenol-soluble modulins (PSMs) (117). In the current studies, 
we applied BioFlux microfluidics technology to provide enhanced resolution ofthe events 
occurring during the early stages of S. aureus biofilm development. In doing so, we have 
identified two additional developmental stages referred to as “multiplication” and 
“exodus” (Figure 3-1), which are distinct from the agr-mediated dispersal events that 
occur after tower formation. In addition, these studies provide greater insight into tower 
development associated with biofilm maturation, as well as the complex regulatory 
strategies that precede this process.  
  
Attachment  
The observation that the initial attachment of cells to the substrate could be 
inhibited by the addition of proteinase K indicates that this process is mediated by 
protein components associated with the cells (Figure 3-2B). Given that the Agr system is 
known to regulate expression of secreted and cell wall-associated proteins in S. aureus 
(190), we tested this strain for its ability to attach in our biofilm assay. As shown in 
Figure 3-5B, we observed an increase in cell attachment in an agr mutant derivative of 
the UAMS-1 strain. This observation is consistent with a previous report showing that 
agr-defective strains exhibit increased adherence to polystyrene in static biofilm assays 
(85). Within this study, it was demonstrated that increased attachment of the agr mutant 
strains was the result of decreased production of the PSM, δ-toxin, which these authors 
speculated may act as a strong surfactant preventing hydrophobic interactions between 
the cell surface and the polystyrene substrate.  
In fact, S. aureus produces numerous surface proteins including the Sas family of 
proteins, fibronectin-binding proteins, clumping factors, elastin-binding proteins, protein 
A, and AtlA that have all been shown to be important for attachment and biofilm 
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maturation (86, 170). To determine the potential role of these proteins in our system, we 
identified NTML mutant strains, as well as others, that contain defects in the synthesis of 
cell surface-associated molecules (i.e. LPXTG-motif proteins, intercellular adhesion, and 
capsule) and screened them for initial attachment (Table 3). This analysis revealed that 
only the atlA::ΦΝΣ mutant exhibited a defect in the initial attachment of cells (Figure 3-
3). In addition, we added PAS, an autolysis inhibitor, in two hour time points to 
developing UAMS-1 wild-type biofilms in the BioFlux1000 and saw abolishment of the 
biofilm two hour following addition of PAS (Figure 3-4). These data are in agreement 
with a recent study that demonstrates that the S. aureus biofilm matrix relies less on cell 
surface-associated proteins including protein A and the fibronectin-binding proteins, and 
more so on cytoplasmic proteins released during stationary phase of growth (191). In 
addition, while AtlA has been reported to serve as an adhesin (86), results have also 
indicated that the enzymatic activity of this protein is required for biofilm formation, 
suggesting the involvement of autolysis and the subsequent release of genomic DNA 
(104). Arguing against this possibility is the observation that the addition of DNase I to 
the inoculum (data not shown) or at the 0-h time (Figure 3-2A) had little effect on the 
attachment of cells. Complicating the interpretation of these results further is the 
propensity of the atlA mutant to form large clusters of cells, which could have detrimental 
effects on cell attachment. Furthermore, the fact that many of the mutants tested did not 
show a defect in biofilm development is not completely unexpected since most of the 
surface proteins are important for binding host matrix components (i.e. MSCRAMMs), 
which are absent in our biofilm assays. Overall, the finding that attachment was affected 
by the agr and atlA mutations, but none of the other cell surface protein mutations, is 
consistent with the hypothesis that AtlA and δ-toxin are required for this process (85). 
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Multiplication  
Similar to cell attachment, the multiplication stage was also found to be sensitive 
to protease treatment (Figure 3-2B); however, screening of the NTML for proteins 
involved in this stage failed to identify a protein important in this process (Table 3). The 
current studies demonstrated that DNase I had little effect on the biofilm during the 
multiplication stage (Figure 3-2A and Figure 3-10). This is in agreement with a recent 
study demonstrating DNase I-insensitivity during early S. aureus biofilm development 
(175). Although these results appear to conflict with our previous findings (99, 100), it is 
important to note that the biofilm growth conditions used here were distinctly different 
from the static assay conditions used previously. In addition, the BioFlux assay affords 
greatly increased resolution of the early events in biofilm maturation through real-time 
microscopic imaging of the cells, thus, enabling the visualization of developmental 
events that were previously undetectable in the static assays. In addition, isolation of 
eDNA from the biofilms at four hours treated with or without active DNase I showed no 
significant changes in eDNA levels although the eDNA levels were lower when treated 
(Figure 3-11). Based on these data, we hypothesize that there is a functional shift in the 
biofilm matrix prior to the exodus event from a protein-based matrix to one that is 
dependent on both eDNA and protein, most likely the result of eDNA and protein 
interactions occurring as the biofilm matures. Indeed, precedence for this includes the 
demonstration that S. aureus beta toxin, normally known for its role as a hemolysin, can 
bind eDNA and covalently cross-link to itself forming an insoluble nucleoprotein matrix 
within a biofilm (108). However, UAMS-1 does not produce beta toxin due to an insertion 
of the bacteriophage in the hlb gene (108). Like beta toxin, the immunodominant surface 
antigen B (IsaB) has also been shown to bind DNA, yet an isaB mutant previously 
exhibited no defect in biofilm formation (109). Likewise, an isaB mutant showed no 
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noticeable differences in biofilm development when grown in the BioFlux1000 when 
compared to it wild-type strain (data not shown).  
In contrast to these extracellular DNA-binding proteins, recent reports have 
demonstrated that cytoplasmic nucleoid-associated proteins (NAPs), normally known for 
intracellular chromosomal structuring, have emerged as possible biofilm scaffolds in 
different bacteria. Specifically, biofilm produced by Burkholderia cenocepacia, non-
typeable Haemophilus influenza, and Escherichia coli have all shown a requirement for 
integration host factor (IHF) and/or histone-like protein (HU). In fact, treatment of 
established biofilms of these species, as well as S. aureus and S. epidermidis, with 
antisera specific for these proteins resulted in a considerable decrease in the total 
amount of biofilm generated (107, 192). The precedence for NAPs in bacterial biofilms 
and the plethora of NAPs identified in S. aureus (193) suggest that these proteins may 
be important contributors to biofilm development in S. aureus. Studies to identify specific 
eDNA-binding proteins important in biofilm integrity are currently in progress in our 
laboratory. 
 
Exodus  
The observation that Agr P3 promoter activity was not observed until well after 
tower development (Figure 3-7), in combination with the absence of an effect of an agr 
mutation on the exodus event (Figure 3-5), suggests that the Agr quorum-sensing circuit 
and the PSMs are not required for exodus. Instead, given the role of eDNA in biofilm 
development we hypothesized that staphylococcal nuclease may be required. 
Consistent with this hypothesis was the observation that the biofilm became DNase I-
sensitive after six hours of development (Figure 3-10), and the Δnuc mutant failed to 
initiate exodus at this time point (Figure 3-9). Given the precise timing of the exodus 
event, we also examined nuc expression and, remarkably observed expression limited to 
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subpopulation of cells preceding the exodus event (Figure 3-12), suggesting that these 
specialized cells have an impact on the remainder of the biofilm population, much like 
the specialization that is seen in Bacillus subtilis biofilm formation (194). In addition, 
these data also suggest a model where early Nuc-mediated exodus allows for tower 
formation and eventual late Agr-mediated dispersal for further dissemination of S. 
aureus cells.  
The observation that nuc exhibited temporal and stochastic patterns of 
expression during biofilm development indicates that it is subject to complex regulatory 
control. While previous reports have suggested that nuclease is regulated by the Agr 
quorum-sensing circuit (195-197), new evidence demonstrates nuc expression is more 
directly controlled by the Sae regulatory system (198-200). Indeed, recent promoter 
mapping, Nuc activity measurements, and immunoblot studies have confirmed the Sae-
dependent regulation of nuclease expression (48). In support of these findings, an agr 
mutant exhibited both temporal and stochastic regulatory control of nuc expression 
during biofilm development similar to the wild-type strain (data not shown). Additionally, 
a saeQRS::spc mutant failed to initiate exodus of the biofilm population and exhibited 
much reduced nuc expression when compared to its parental strain AH1263 (Figure 3-
13). The saePQRS operon encodes two auxiliary proteins, SaePQ, and a two-
component system, SaeRS, that globally regulate multiple S. aureus secreted proteases 
(201) and virulence factors such as alpha toxin, beta toxin (hlb), coagulase (coa), 
fibronectin-binding proteins (fnbA and fnbB), and extracellular adherence protein (eap) 
(202, 203). To continue to dissect the potential roles that each protein in the saePQRS 
operon has during nuc expression and biofilm development, we obtained mutations in 
three of the four genes (i.e. ∆saeP, ∆saeQ, and ∆saeS) and a complete deletion of the 
entire operon, ∆saePQRS. Most interestingly, the ∆saeP demonstrated a unique 
phenotype where apparently every cell in the developing biofilm expressed nuclease 
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compared to the subpopulation of cells seen in wild-type (Figure 3-15). This is 
particularly significant given that work by another group has demonstrated that the SaeP 
protein can bind eDNA (unpublished data from Alexander Horswill laboratory) and the 
recent study proposing that the SaeP and SaeQ form a complex to initiate phosphatase 
activity of the sensor kinase SaeS (203) may explain this unique expression phenotype. 
Given the former, along with several examples of bacterial cells sensing their ECM to 
initiate biofilm cell responses (204), we hypothesized that the SaeP protein may be 
sensing eDNA as a feedback mechanism to control nuc expression during biofilm 
development. Thus, we added exogenous DNA to the developing biofilm, and to our 
surprise, the additional DNA almost completely prevented biofilm formation (Figure 3-
17), making it impossible to evaluate nuc expression. Interestingly, this effect was similar 
to that observed for PAS-treated biofilms, or cells that contain an atlA mutation (Figure 
3-3), both of which are unable to form biofilms due to a lack of lysis. Considering the 
recent data demonstrating that the glucosaminidase domain of AtlA binds DNA (205), 
one possible explanation for this phenomenon is that exogenously added DNA is binding 
to AtlA and inhibiting its function, and ultimately leading, to inhibition of biofilm 
development. However, this possibility is still being investigated. 
Since we were unable to add additional DNA to a S. aureus biofilm, we 
performed planktonic studies to determine any effects on nuc expression. 
Counterintuitively, when increasing amounts of salmon sperm DNA were added to 
planktonically growing cells, there was a clear decrease in nuc expression (Figure 3-18), 
yet, it appeared to be SaeP-independent (Figure 3-19). This is in contrast to our 
expectations considering if more of the substrate for nuclease (i.e. eDNA) is present, 
one would imagine that an increase in nuclease activity would occur and the Sae-control 
would be eliminated in a saeP mutant. However, this does not appear to be the case. 
Nonetheless, one possible explanation for the increase in nuc expressing cells in the 
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biofilm in a ∆saeP mutant may be due to the fact that SaeQ cannot form a complex with 
SaeP and activate the phosphatase activity of SaeS resulting in uncontrolled expression 
of nuclease throughout a biofilm. 
In addition to evaluating the effect of exogenous DNA on nuc expression, we also 
evaluated the effect of exogenous DNA on S. aureus overall growth. When DNA was 
added from initial inoculation of planktonically grown cells, there is a clear increase in 
growth yield from 6-12 hours when compared to strains grown in TSB not containing 
additional DNA (Figure 3-20). Although this is not a Sae-controlled process (Figure 3-
20), it seems that S. aureus may be able to use DNA as an additional carbon source. 
This may be possible considering the primary carbon source, glucose, in TSB is 
exhausted by six hours (154) and other bacteria such as Vibrio cholerae have shown the 
ability to use DNA as a nutrient source (206). As an alternative hypothesis, the 
exogenous DNA could be killing the cells but not lysing because the activity of Atl may 
inhibited.  
Lastly, considering that the Sae system regulates so many different genes, we 
asked whether other Sae-regulated promoters, such as those driving hla, hlgA, P1sae, 
and coa expression, demonstrated similar expression patterns in a developing S. aureus 
biofilm. Surprisingly, the hla, P1sae, and coa promoters all showed similar stochastic 
expression to nuc. In contrast, no hlgA expression was observed (Figure 3-21). In 
addition, a coa/nuc dual reporter construct revealed overlapping expression patterns 
(Figure 3-22), demonstrating that subpopulation of cells is responsible for the expression 
of at least two different secreted proteins. While it is fascinating that these other Sae-
regulated factors appear to be stochastically regulated in subpopulation of cells, one 
interesting observation amongst these data is the fact that hla and coa have similar 
expression patterns even though they are in different “classes” of Sae regulation. These 
classes refer to whether or not the expression of a particular gene is dependent on the 
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phosphorylation state of SaeR (202). Indeed, class I sae target genes (coa, fnbA, eap, 
sbi, efb, fib, nuc, and sae) require phosphorylation of SaeR while the class II target 
genes (hla, hlb, and cap) seem to be less reliant on this phosphorylated state (202). 
Since the nuc and coa are in the same class, it is not surprising that the two genes are 
expressed in the same biofilm population. This suggests that a Sae-regulated 
mechanism is activated to control the overproduction of certain virulence factors and 
delineate roles to certain subpopulations of cells. In addition, the data demonstrating 
similar expression patterns between hla and nuc in a biofilm suggests that there may be 
much more to the control of hla, yet, construction of a nuc/hla reporter could provide 
further insight into whether or not both of these genes are expressed in the same biofilm 
cell population. This additional control may be under the Agr quorum-sensing system, 
given that the large 5’ untranslated region (5’ UTR) of hla mRNA can be bound by 
RNAIII leaving the Shine-Dalgarno sequence to be bound by ribosomes and leaving hla 
under translational control in addition to transcription regulation (207). In addition to hla 
expression patterns, another observation that hlgA expression was undetectable even in 
the wild-type strain. Recent data suggesting that hlgA expression is dependent on 
activation by host cell antimicrobials such as α-defensin (157), may explain why it is not 
expressed in an in vitro biofilm assay.  Thus, further studies must be continued to 
evaluate the regulation of these Sae-factors and others by examining not only Sae 
control, but also the interplay of other regulators such as Agr or SarA or the newly 
identified virulence factor regulatory locus, vfrAB operon, which appears to be an 
upstream regulator of the Sae regulon (208)   
Tower Maturation Stage   
Based on the results of this study, it is apparent that the early exodus event 
during S. aureus biofilm development is essential for the formation of distinct tower 
structures, which based on our previous studies (148) have variable physiology and 
83 
 
 
 
metabolism as seen by the presence or absence of eDNA and dead cells as well as 
differential gene (cid and lrg) expression. However, two major questions remain to be 
answered. First, how do these eDNA-containing towers remain intact if nuclease is 
active? A recent report testing DNase I efficacy in UAMS-1 S. aureus biofilms 
demonstrated carbohydrates (likely, PIA) and eDNA staining within tower structures and 
appear to be DNase I insensitive (175). The authors suggest that carbohydrates may be 
interacting with eDNA and protecting it from DNase I degradation, however, further 
investigation must be conducted to confirm these findings.  
Second, what is the function of towers in S. aureus biofilm? Some evidence 
suggests that tower structures are important for the pathogenesis of S. aureus biofilms 
formed on native heart valves of infective endocarditis where they detach and travel to 
secondary sites of infection (64, 103, 209). In other organisms, the development of 
specialized structures is important for survival and/or resistance to environmental 
stresses. For example, the cystic fibrosis pathogen, Pseudomonas aeruginosa, forms 
robust tower-like structures that have been shown to be important in resisting microbial 
biocides such as sodium dodecyl sulfate (SDS) detergent and tobramycin (210, 211), as 
well as mediating biofilm dispersal (138). Additionally, the predator bacterium, 
Myxococcus xanthus, demonstrates complex multicellularity and intercellular signaling 
through coordinated gene expression to form raised aggregates of cells called fruiting 
bodies (212-214). Indeed, much like the reduction of the cell population during the 
exodus phase that precedes tower formation in S. aureus, M. xanthus demonstrates a 
reduction of the cell population preceding fruiting body development (215, 216). Based 
on these similarities, it is likely that tower structures produced by S. aureus are also 
important in survival during environmental stress. 
Finally, the results of our studies suggest an alternative to the model proposed by 
Otto (76) describing how S. aureus biofilms develop their characteristic structure. In this 
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model, it is envisioned that the PSMs act upon a preexisting thick mat of cells, causing 
cell detachment and leaving behind structures of various forms (e.g. towers and 
channels). However, the structures present in the biofilms produced in our biofilm 
system are clearly not generated in this way. Rather, they are formed after the mass 
exodus of the bulk of the early biofilm, and appear to arise as a result of the rapid growth 
of only a few remaining cells. In the absence of staphylococcal nuclease, these tower 
structures are not observed, either because they are overwhelmed by the presence of 
an unusually robust accumulation of biomass, or because a key developmental switch 
fails to trigger. Continued studies are required to provide a greater understanding of 
these fascinating developmental processes, as well as the functions of the structures 
that are formed. 
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CHAPTER IV: 5 
Correlation of cell death/extracellular DNA and expression of the cidABC and 
lrgAB operons during Staphylococcus aureus biofilm development 
 
INTRODUCTION 
 The primary focus of our laboratory has been the characterization of two S. 
aureus operons, cidABC and lrgAB, and their roles in programmed cell death (PCD) and 
biofilm development. Although the exact mechanisms have yet to be elucidated, 
previous studies of planktonic cultures have shown that the cid and lrg operons respond 
to alterations in carbon overflow (overflow metabolism) (217) (218) (219).  Although not 
completely understood, overflow metabolism (i.e. conditions of excess glucose and 
oxygen) is a phenomenon in which carbon flow into the TCA cycle is limited by carbon 
catabolite repression (220) (221) (222) (223).  Thus, carbon is redirected into various 
pathways including the Pta/AckA and AlsS/AlsD pathways, accumulating extracellular 
acetate and acetoin, respectively, and consuming intracellular pyruvate (224).   
Interestingly, CidR, the LysR-type transcriptional regulator (LTTR) that induces co-
expression of cidABC and alsSD operons, is known to be induced by high 
concentrations of acetate under conditions of carbon overflow (i.e. 35 mM glucose) (217) 
(217) (219).  Intriguingly, the cidC and alsSD genes are known to encode three 
metabolic enzymes, specifically involved in overflow metabolism: pyruvate oxidase 
(CidC), acetolactate synthase (AlsS), and acetolactate decarboxylase (AlsD), that have 
also recently been shown to play additional opposing roles in PCD and biofilm 
development (219).  Opposing the cid operon in PCD, the lrgAB operon is regulated by 
                                                          
The majority of the work in CHAPTER IV has been published in Moormeier DE, 
Endres JL, Mann EE, Sadykov MR, Horswill AR, Rice KC, Fey PD, Bayles KW. 
AEM. 2013. 
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LytSR, a two-component regulatory system (TCRS) (225) (174). LytSR is known to 
induce lrgAB expression by sensing changes in membrane potential, as demonstrated 
using membrane-dissipating agents, such as carbonyl cyanide m-
chlorophenylhydrazone (CCCP) and gramicidin, altering cell death and lysis and leading 
to biofilm modulations and decreased biofilm adherence (226).  Additionally, it has been 
shown that, under conditions of overflow metabolism, that lrgAB is induced in a LytSR-
dependent manner, coinciding with extracellular acetate accumulation (217).  In addition, 
our results also demonstrate that lrg expression can also be induced in a LytS-
independent manner as a result of increased levels of acetyl-phosphate, an overflow 
intermediate metabolite, which acts as a phoshodonor to phosphorylate LytR (227) (228) 
(229) (230).   
 Collectively, these data suggest that the cid and lrg operons respond to 
alterations of central metabolism, which are dependent on the conditions of the 
surrounding environments including oxygen levels, glucose levels, and pH.  However, 
modulations of central metabolism and their roles in biofilm development have yet to be 
completely illuminated.  Thus, the studies described in this chapter were designed to 
assess the metabolic heterogeneity of developing biofilm microenvironments and the 
roles they play in the differential expression the cid and lrg operons. 
 
RESULTS 
Induction of cid and lrg expression during hypoxic growth 
 Previous studies of cidABC and lrgAB transcription showed that expression of 
both of these operons was induced during aerobic overflow metabolism (143) where the 
high rate of glycolysis inhibits aerobic respiration and induces carbon flow through 
fermentation pathways (231). Since staphylococcal biofilms contain regions of hypoxia 
(142), we hypothesized that the decrease in oxygen concentrations, leading to activation 
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of fermentative metabolism, will also affect cid and lrg expression. To test this, RNA was 
extracted from aerobically- and hypoxically-grown cells at 4 hr post inoculation and the 
relative levels of cid- and/or lrg-transcripts were determined using quantitative reverse 
transcriptase PCR (qRT-PCR). Measurements of oxygen revealed that hypoxic growth 
resulted in an oxygen concentration of approximately 1% total saturation, compared to 
approximately 70% total oxygen saturation under our standard growth conditions (see 
Chapter II). As anticipated, the levels of the cid-specific transcripts were markedly 
increased (approximately 12 fold) in cells grown under hypoxic conditions compared to 
cells grown aerobically (Figure 4-1A). Consistent with previous studies (145), cid 
expression was induced under excess glucose conditions in a cidR-dependent but 
lytSR-independent manner, respectively (data not shown). Similarly, the induction of cid 
expression under hypoxic conditions was found to be cidR dependent and lytSR 
independent (Figure 4-1A). In contrast, lrgAB transcription was found to be slightly 
decreased under hypoxic conditions, but remained lytSR dependent (Figure 4-1B) as 
previously demonstrated (159, 232). Additionally, we found that lrgAB expression was 
not influenced by the cidR mutation during growth under hypoxic conditions (Figure 4-
1B). Taken together, these data demonstrate that hypoxic conditions induce cidABC 
operon expression in a CidR-dependent manner, similar to its induction observed during 
overflow metabolism. However, unlike the induction of lrgAB expression previously 
observed during overflow metabolism, hypoxic growth does not affect lrgAB 
transcription.  
 
Expression of cid and lrg in individual cells  
 To test the hypothesis that the cid and lrg operons are differentially expressed 
within a growing biofilm, we generated cid and lrg transcriptional reporter fusions to 
facilitate the assessment of expression of these genes in individual cells during different 
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Figure 4-1 Hypoxic induction of cidABC and lrgAB transcription 
 
Total RNAs were collected from S. aureus WT (UAMS-1), cidR mutant, 
and lytSR mutant cells at 4 h of growth under aerobic and hypoxic conditions. 
The cidABC (A) and lrgAB (B) transcripts present in the RNA were detected by qRT-
PCR with cidA- and lrgA-specific primers, normalized to the levels of sigA-specific 
transcripts detected, and then plotted as n-fold changes relative to the cidABC and lrgAB 
transcript levels in WT cells grown under aerobic conditions. Error bars represent 
standard deviations generated from three independent experiments. In panel A, 
significant differences (P < 0.05 for all) between aerobic and hypoxic treatments are 
denoted as follows: *, WT; **, ΔlytSR. In panel B, significant differences (P < 0.05 for all) 
between aerobic and hypoxic treatments are denoted as follows: *, WT; **, ΔcidR. 
 
Figure modified from Moormeier et al. 2013. AEM 
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 stages of biofilm development. Promoter regions of both the cid or lrg operons were 
amplified and inserted upstream of the gene encoding super-folder GFP (sGFP), 
previously shown to be easily detected in S. aureus cultures (160). The resulting 
constructs were moved into UAMS-1, as well as the cidR and lytSR derivatives of this 
clinical isolate. The strains were tested to determine if GFP expression during planktonic 
growth reflected the transcriptional regulation seen by Northern blot analyses (143, 145, 
232) and using qRT-PCR analyses (Figure 4-1). Indeed, when grown in the presence of 
excess glucose or under hypoxic conditions, the Pcid::gfp reporter construct produced 
increased levels of GFP fluorescence (Figure 4-2), as opposed to aerobically grown cells 
in the absence of glucose, and was cidR-dependent (Figure 4-2). In contrast, the 
Plrg::gfp promoter construct did not produce detectable fluorescence under these 
conditions (Figure 4-2). However, when grown in the presence of CCCP, a membrane 
potential dissipating agent known to induce lrgAB expression, the Plrg::gfp promoter 
construct fluoresced brightly in a lytSR-dependent manner (Figure 4-3). As a control, we 
also generated a gfp fusion to the ldh1 promoter that is specifically expressed during 
hypoxic growth (233). In wild type cultures containing the Pldh1::gfp promoter fusion 
grown in hypoxic conditions, GFP fluorescence was seen in the majority of cells as 
compared to the absence of fluorescence in cells grown aerobically in the presence or 
absence of excess glucose (Figure 4-2).  
 
Expression of cid and lrg operons during biofilm development 
 To study cid and lrg expression within a biofilm, we first examined the fluorescent 
reporter constructs in biofilm grown under static conditions. As shown in Figure 4-4 
(panels A and C), GFP fluorescence was observed in biofilm formed by the wild-type 
strain containing the cid fusion, but not in the cidR mutant, similar to growth under 
planktonic conditions (Figure 4-1). Also similar to planktonic growth (Figure 4-2), the 
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Figure 4-2 Expression of fluorescent reporters during planktonic growth 
 
S. aureus UAMS-1 (185), the cidR mutant (ΔcidR) strain, and the lytSR mutant (ΔlytSR) 
strain containing the Pcid::gfp, Plrg::gfp, and Pldh::gfp transcriptional reporter plasmids 
were grown to exponential phase in the presence or absence of 35 mM glucose and 
under aerobic and hypoxic conditions as indicated. GFP-positive cells were visualized by 
CLSM at ×630 magnification as described in Materials and Methods. The scale bar 
represents 5 μm. 
 
Figure modified from Moormeier et al. 2013. AEM 
 
 
 
91 
 
 
 
 
 
Figure 4-3 CCCP induction of lrgAB promoter activity 
 
S. aureus UAMS-1 (panels A and B) and its lytS mutant derivative, KB999 (panels C and 
D), each containing the Plrg::gfp promoter fusion plasmid, were grown to mid-
exponential phase and treated with CCCP, a depolarizing agent previously shown to 
induce lrgAB transcription. GFP positive cells were visualized by confocal laser scanning 
microscopy as described in Materials and Methods. Scale bar represents 5 µm. 
 
Figure modified from Moormeier et al. 2013. AEM 
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 lrgAB promoter was not expressed in a static biofilm (Figure 4-4D). As anticipated 
based on previously published results demonstrating the hypoxic nature of static biofilms 
(142), the ldh1 promoter fusion construct also expressed GFP fluorescence in our static 
biofilm assays (Figure 4-4B).  
 To examine the pattern of cid and lrg expression during biofilm development 
under flow cell conditions, we took advantage of BioFlux1000 technology (147) to 
acquire sequential bright-field and epifluorescence images of a developing biofilm. 
Analysis of the epifluorescent images revealed distinct patterns of cid and lrg expression 
during the development of these biofilms. Using the UAMS-1 Pcid::gfp fusion strain 
(Figure 4-5), distinct clusters of cells or “towers” emerged and gradually turned green as 
they increased in size, similar to the pattern of expression observed with the Pldh1::gfp 
fusion strain (Figure 4-6), consistent with the hypothesis that hypoxic regions of the 
biofilm (within the interior of the large towers) induce cid expression. Unexpectedly, the 
Pcid::gfp fusion strain also produced smaller towers with constitutively high levels of 
fluorescence (Figure 4-7), clearly distinct from the larger towers. These smaller towers 
appear to emerge from a single highly fluorescent cell that divides (although with a 
seemingly slower growth rate compared to the other clusters) and remains exclusively 
associated with its siblings until a large, intensely fluorescent tower was formed. In 
addition, these towers appeared to be less adherent, as demonstrated by their 
propensity to release smaller cell clusters (Figure 4-7). Importantly, similar highly 
fluorescent towers were observed using the Pldh1::gfp fusion strain (Figure 4-8), 
suggesting that overlapping metabolic cues may be responsible for high level cid and 
ldh1 expression observed in these small towers. Also, no Pcid::gfp-mediated 
fluorescence in either tower type was observed in a strain in which the cidR gene had 
been disrupted (data not shown), suggesting that the signals responsible for cid 
expression in both tower types were similar. 
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Figure 4-4 Analysis of cid and lrg expression during static biofilm growth 
 
S. aureus UAMS-1 cells containing: (A) Pcid::gfp promoter fusion in UAMS-1 [UAMS-1 
(pEM81)], (B) Pldh1::gfp promoter fusion in UAMS-1 [UAMS-1 (pEM87)], (C) Pcid::gfp 
promoter fusion in the cidR mutant [KB1090 (pEM81)], and (D) Plrg::gfp promoter fusion 
in UAMS-1 [UAMS-1 (pEM80)]. Three-dimensional images of the biofilms were 
generated using confocal laser scanning microscopy as described in the Materials and 
Methods. Images are representative of three independent experiments. Scale bar 
represents 40 µm. 
 
Figure modified from Moormeier et al. 2013. AEM 
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Figure 4-5 Temporal analysis of cidABC expression during biofilm development 
 
S. aureus cells containing the Pcid::gfp reporter plasmid were inoculated into a BioFlux 
microfluidic system and allowed to form a biofilm within a flow shear environment at a 
flow rate of 64 μl/h for a total of 18 h. Bright-field and epifluorescence microscopic 
images were collected at 5-min intervals. The images presented were taken from the 
complete set of 217 images taken at ×200 magnification, spanning 9 to 14.5 h, and 
illustrate typical tower development and GFP expression observed in multiple 
experiments. The scale bar represents 50 μm. 
 
Figure modified from Moormeier et al. 2013. AEM 
 
 
 
95 
 
 
 
 
 
 
 
 
Figure 4-6 Temporal analysis of ldh1 expression during biofilm development 
 
S. aureus cells containing the Pldh1::gfp reporter plasmid were inoculated into a BioFlux 
microfluidics system and allowed to form a biofilm within a flow-shear environment at a 
flow rate of 64 µl/h for a total of 18 h. Bright-field and epifluorescence microscopic 
images were collected at 5-min intervals using 200× magnification. The images 
presented were taken from the complete set of 217 images spanning 12.5-18 h and 
illustrate typical tower development and GFP expression observed in multiple 
experiments. Scale bar represents 50 µm. 
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Figure 4-7 High-level cid expression in small towers during biofilm formation 
 
S. aureus cells containing the Pcid::gfp reporter plasmid were inoculated into a BioFlux 
microfluidic system and allowed to form a biofilm as described in the legend to Figure 4-
5. The image shown (at ×200 magnification) represents a typical constitutive highly 
fluorescent “small” tower that is formed by this strain, distinct from the delayed 
fluorescence produced by the “large” towers depicted in Figure 4-5. Note the presence 
of detached, highly fluorescent cells “downstream” (to the right) of the tower. The scale 
bar represents 50 μm. 
 
Figure modified from Moormeier et al. 2013. AEM 
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Figure 4-8 High-level ldh1 expression in small towers during biofilm formation 
 
S. aureus cells containing the Pldh1::gfp reporter plasmid were inoculated into a BioFlux 
microfluidic system and allowed to form a biofilm as described in the legend to Figure 4-
5. The image shown (at ×200 magnification) represents a typical constitutive highly 
fluorescent “small” tower that is formed by this strain, distinct from the delayed 
fluorescence produced by the “large” towers depicted in Figure 4-6. Note the presence 
of detached, highly fluorescent cells “downstream” (to the right) of the tower. 
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 The UAMS-1 Plrg::gfp fusion strain exhibited a different pattern of expression 
during biofilm development (Figure 4-9). Similar to the cid and ldh1 promoter fusion 
constructs, the Plrg::gfp fusion strain produced fluorescence in what appeared to be the 
large towers that exhibited inducible cid and ldh1 expression as the towers matured. 
However, unlike what was observed with the cid and ldh1 promoter fusion constructs, 
the Plrg::gfp fusion strain produced constitutive fluorescence without increasing 
expression within growing towers, consistent with results indicating that this promoter is 
not inducible under hypoxic conditions. Importantly, it should be noted that despite the 
fact that the Plrg::gfp fusion strain did not produce detectable fluorescence in planktonic 
culture or static biofilm assays, this strain produced robust fluorescence within towers 
formed in this flow-cell system suggesting that this operon is controlled by 
developmental signals associated with biofilm formation. As expected, the fluorescence 
produced by the Plrg::gfp construct was abolished in a lytSR mutant background (101).  
 To clearly distinguish the coincidence of cid and lrg expression within the tower 
structures, a dual cid/lrg reporter strain was also generated. The cid promoter was fused 
to the gene encoding sGFP, and the lrg promoter was fused to the gene encoding 
DsRed.T3 (DNT). Wild-type UAMS-1 containing this construct was grown using the 
BioFlux system and observed during biofilm development. As shown in Figure 4-10, lrg 
expression (red fluorescence) was detected early in the development of the towers (12 
h) followed by the emergence of cid expression (green fluorescence) as the towers 
increased in size (starting at 16 h). Distinct small towers expressing high levels of cid 
were also observed (arrows), similar to those produced by the Pcid::gfp fusion strain 
(Figure 4-6). As shown in Figure 4-11, which illustrates the fluorescence detected using 
the different filter sets, the small towers clearly express a high level of cid-associated 
sGFP fluorescence and nearly undetectable levels of lrg-associated DsRed 
fluorescence, while the large towers express both promoters, albeit in different temporal 
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Figure 4-9 Temporal analysis of lrgAB expression during biofilm development 
 
S. aureus cells containing the Plrg::gfp reporter plasmid were inoculated into a BioFlux 
microfluidic system and allowed to form a biofilm within a flow shear environment at a 
flow rate of 64 μl/h for a total of 18 h. Bright-field and epifluorescence microscopic 
images were collected at 5-min intervals at ×200 magnification. The images presented 
were taken from the complete set of 217 images spanning 9 to 14.5 h and illustrate 
typical tower development and GFP expression observed in multiple experiments. The 
scale bar represents 50 μm. 
 
Figure modified from Moormeier et al. 2013. AEM 
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Figure 4-10 Simultaneous temporal analyses of cidABC and lrgAB expression 
during biofilm development 
 
S. aureus cells containing the Pcid::gfp and Plrg::sDsRed dual-reporter plasmid were 
inoculated into a BioFlux microfluidic system and allowed to form a biofilm within a flow 
shear environment at a flow rate of 64 μl/h for a total of 18 h. Bright-field and 
epifluorescence microscopic images were collected at 5-min intervals at ×200 
magnification. The images presented were taken from the complete set of 217 images 
spanning 12 to 17.5 h and illustrate the typical tower development and GFP and 
DsRed.T3(DNT) expression observed in multiple experiments. The scale bar represents 
50 μm. The arrows indicate the small, highly fluorescent cid-expressing towers. 
 
Figure modified from Moormeier et al. 2013. AEM 
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Figure 4-11 Differential expression of cid and lrg within different towers 
 
The individual images collected at 17 h from Figure 4-10 are presented to better 
illustrate the green and red fluorescence produced by the S. aureus Pcid::gfp and 
Plrg::sDsReddual-reporter strain (at ×200 magnification). The panels include images 
collected by bright-field microscopy only (A), a bright-field microscopy and FITC overlay 
(B), a bright-field microscopy and TRITC overlay (C), and a bright-field microscopy, 
FITC, and TRITC overlay (D). The scale bar represents 50 μm. The arrows indicate the 
small, highly fluorescent cid-expressing towers. 
 
Figure modified from Moormeier et al. 2013. AEM 
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 patterns. These data confirm the existence of two distinct towers types, one that is 
characterized by rapid cell division, constitutive lrg expression, and gradual cid 
expression induced presumably as the tower enlarges and becomes hypoxic, and the 
other that exhibits relatively slow cell division and high, constitutive levels of cid 
expression.  
 
Correlation of lrg expression with cell death and lysis 
 Previous studies using confocal laser scanning microscopy demonstrated that 
tower structures contain a high number of dead cells and/or eDNA as indicated using 
viability staining techniques (100). Subsequent lysis of the dead cells resulted in clear, 
cell-free voids that likely contain cell debris, including released genomic DNA. This 
pattern of death and lysis causing a “hollowing out” of tower structures appears to be 
conserved in other bacterial species (138, 234), including a positive role for P. 
aeruginosa cid and a negative role of lrg orthologs in this process (138). To determine if 
cid and/or lrg expression correlated with cell death and lysis under these flow-cell 
conditions, we grew our Pcid::gfp and Plrg::gfp fusion constructs in the BioFlux system 
and stained the biofilm with propidium iodide (PI) to visualize dead cells and eDNA. As 
shown in Figure 4-11, the large towers expressing both cid and lrg were readily stained 
with PI, exhibiting a relatively uniform fluorescence intensity throughout these structures 
(see top and bottom panels), similar to the uniform GFP-mediated fluorescence 
produced by the Plrg::gfp fusion construct. Analysis of the temporal pattern of PI staining 
also corresponded well with lrg expression with staining of the tower occurring early in 
development and continuing as they grew in size. This is in contrast to the Pcid::gfp 
reporter construct, which is expressed in the center of the tower structures only after 
they have reached a certain size, presumably corresponding to the hypoxic regions of 
the towers (see above). Interestingly, the smaller, intensely fluorescent green towers that 
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Figure 4-12 Correlation of eDNA/cell death with cidABC and lrgAB expression 
within a biofilm 
 
S. aureus WT cells carrying the Pcid::gfp and Plrg::gfp reporter plasmids were 
inoculated into a BioFlux microfluidic system and grown into biofilms as described in the 
legend to Figure 4-5. The biofilm was grown in 50% TSB medium containing 0.125 μM 
PI stain (184) to stain dead cells and eDNA. Individual images captured at 17 h 
demonstrate an overlap of lrg expression (green) and dead cells/eDNA (184) in large 
towers (top and bottom panels) and the absence of lrg expression and dead cells/eDNA 
in small towers (middle panels). The scale bar represents 50 μm. 
 
Figure modified from Moormeier et al. 2013. AEM. 
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 constitutively express the cid promoter (Figure 4-12; middle panels) did not retain the PI 
stain, also similar to the absence of expression observed in these structures (Figures 4-
10 and 4-11). Overall, the results of these studies demonstrate an association with the 
patterns of cid and lrg expression within a developing biofilm corresponds with the 
presence of dead cells and/or eDNA in tower structures. 
 
Mutations in Pta-AckA pathway increase highly-constitutive cid expressing small 
towers during biofilm development 
 Given the intimate relationship with overflow metabolic pathways and the 
changes in expression of the cidABC and lrgAB operons, we wanted to determine the 
effects that mutations in different metabolic pathways had on expression of the cid and 
lrg operons as wells as biofilm morphology. Recently, inactivation of the 
phosphotransacetylase-acetate kinase (Pta-AckA) pathway has been demonstrated to 
increase cell death and increased expression of the CidR regulon, which includes 
cidABC (154). Therefore, we moved our dual cid and lrg reporter plasmid (pDM4) into 
∆ackA::ermB and ∆pta mutants and evaluated cid and lrg expression as well as biofilm 
morphologies. Strikingly, the ∆ackA::ermB and ∆pta mutants demonstrated increased 
cidABC expression, as well as an increased number of what appear to be the small high 
cid-expressing towers observed in the wild-type strain (Figure 4-13). Additionally, no lrg 
expression was observed in either mutant strain (Figure 4-13), in contrast to what was 
previously observed in these mutants grown planktonically (101). Together, these results 
demonstrate an intimate relationship between metabolic pathways and the expression of 
the cid and lrg operons and the changes that can occur during tower development in the 
later stages of biofilm development. 
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Figure 4-13 High-level cid expression and increased small towers in ackA and pta 
mutants during small formation  
 
S. aureus mutants ∆ackA::ermB and ∆pta cells containing the Pcid::gfp reporter plasmid 
were inoculated into a BioFlux microfluidic system and allowed to form a biofilm as 
described in the legend to Figure 4-5. The image shown (at ×200 magnification) 
represents a typical constitutive highly fluorescent “small” tower that is formed by this 
strain. The scale bar represents 50 μm. 
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DISCUSSION 
 
 Previous studies in our laboratory have suggested a role for S. aureus cid- and 
lrg-mediated cell death and lysis during biofilm development (99, 100). Implicit in this 
model is that there is heterogeneity in the expression of these operons such that only 
subpopulations of the biofilm cells will die and lyse. Indeed, viability stains clearly 
revealed marked heterogeneity in the distribution of dead cells within the basal biofilm 
layers, and more pronounced cell death and lysis associated with tower structures (100). 
Although these observations suggest that variations in cid and lrg expression may exist 
within different regions of a biofilm, our current understanding of cid and lrg regulation 
has been limited to studies in which the expression of these operons was assessed 
during planktonic growth, where the results generated represent an average level of 
expression throughout the population. For example, glucose metabolism in planktonic 
cultures was shown to induce cidABC expression via the LysR-type transcriptional 
regulator (LTTR) encoded by the cidR gene (143-145). Additionally, the two-component 
regulatory system, LytSR, was shown to induce lrgAB transcription in response to 
changes in membrane potential (146, 159). Although both of these studies provided an 
appreciation for the metabolic signals important in the control of cid and lrg expression, 
neither afforded any insight into the heterogeneity of gene expression within the 
population nor how expression of these operons might be affected by growth in the 
context of a multicellular biofilm. Thus, a key focus of this study is to gain a better 
understanding of how these and/or related metabolic signals are involved in coordinating 
cid and lrg expression during biofilm development. 
 In the first part of this study, we demonstrate that in addition to being induced by 
growth in the presence of excess glucose, cid expression is also induced during growth 
in a hypoxic environment (Figure 4-1), conditions known to predominate within a biofilm. 
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In fact, aerobic growth in the presence of excess glucose is well-known to induce a 
physiological change in cells that results in a shift from oxidative phosphorylation to 
substrate-level phosphorylation in which less oxygen is consumed (235). This so-called 
“Crabtree effect” may, thus, produce metabolic intermediates during aerobic growth that 
stimulate CidR-dependent expression of the cid operon that would normally be produced 
during hypoxic growth. In agreement with the notion that similar metabolic signals are 
sensed during these seemingly disparate conditions is the observation that cid 
expression under hypoxic conditions was found to be cidR dependent, similar to the 
induction of this operon during growth in the presence of excess glucose (Figure 4-1). As 
cidR encodes a member of the LysR-type transcription regulator (LTTR) family of 
proteins, whose members are activated by the binding of specific small effector 
molecules, the effector interacting with CidR likely reflects the metabolic similarities that 
form the basis of the Crabtree effect. Although the identity of this molecule remains to be 
determined, it was recently speculated that pyruvate or an intermediate of pyruvate 
metabolism could serve this purpose based on the observations that CidR-mediated 
control occurs under conditions favoring fermentative metabolism, as well as the fact 
that the CidR regulon includes two operons, both of which encode enzymes involved in 
pyruvate metabolism (231). Interestingly, recent studies indicate that pyruvate plays a 
key role in the formation of microcolonies in Pseudomonas aeruginosa (236). 
 It seems clear that the expression and/or function of the cid and lrg operons must 
be a population-dependent phenomenon, given the observation that there is a mixture of 
live and dead cells within biofilms. Because cell death and lysis are particularly 
predominant within tower structures (100), we hypothesized that the level of cid 
expression relative to lrg is increased in tower structures compared to the surrounding 
basal layer of cells (123). The differences in expression may be a function of localized 
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microenvironments in which reduced oxygen is present. Indeed, oxygen and nutrient 
gradients have been shown to exist in biofilm and have been implicated in signaling 
heterogeneity within the biofilm (142, 237, 238). Furthermore, P. aeruginosa (239, 240) 
and B. subtilis (241-243) demonstrate heterogeneous expression of genes within the 
biofilms they produce. Based on the impact of hypoxic growth on cid and lrg expression, 
we reasoned that variations in oxygen levels within a biofilm play an important role in the 
differential control of cid and lrg expression, and subsequent cell death and lysis within 
these metabolically diverse communities. Thus, to examine the differential control of cid 
and lrg expression during biofilm development, transcriptional fusions of cid and lrg 
promoter regions with a gfp reporter gene were generated and introduced into S. aureus 
wild-type, cidR, and lytSR mutant strains. We took advantage of newly developed 
BioFlux technology (147) that allowed us to simultaneously monitor biofilm growth and 
reporter gene expression under flow-cell conditions over an extended time-course 
experiment, mimicking a more physiologically relevant environment. Strikingly, growth of 
the cid and lrg reporter strains revealed clear temporal and spatial control of these 
genes. For the cid::gfp strain, fluorescence increased over time in large tower structures 
(Figure 4-5 and Figure 4-10), similar to the ldh::gfp strain (Figure 4-6) and consistent 
with the hypothesis that reduced oxygen levels within these structures was responsible 
for the up-regulation of these genes. In addition, a second highly fluorescent 
subpopulation of cells was observed in the cid::gfp fusion strain that was clearly distinct 
from those associated with large tower structures (Figures 4-7, 4-10, and 4-11). In 
contrast to the latter, the highly fluorescent subpopulation appeared to emerge from 
single cells that multiplied and formed distinct tower structures that appeared less 
adherent as evidenced by the observation that they tended to release small cell clusters 
likely as a result of shear forces in this flow-cell environment (Figure 4-7). Thus, the 
differences in gene expression observed between the two tower types identified in this 
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study appear to be associated with fundamentally distinct physical characteristics, such 
as matrix composition, although this remains to be investigated. Importantly, the lack of 
a genetically stable highly fluorescent population of cells within the effluent (data not 
shown) suggests these highly fluorescent towers are not a result of a regulatory mutation 
(e.g. - within the cidR gene).  
The lrgAB::gfp strain also generated a fluorescent signal that was associated 
with tower structures (Figure 4-9). Although the kinetics of this induction were clearly 
distinct compared to the delayed, gradual emergence of fluorescence observed in the 
large towers produced by the Pcid::gfp and Pldh1::gfp fusion strains, it was similar in 
some respects to the small towers expressing high levels of GFP fluorescence. 
However, a dual reporter construct allowed us to determine the relationship between cid 
and lrg expression within individual towers and clearly demonstrated that towers 
exhibiting a gradual increase in cid expression were also constitutively expressing lrg. In 
contrast, towers expressing constitutively high cid levels were expressing low to 
undetectable levels of lrg. The differences in cid and lrg expression undoubtedly reflect 
the fact that expression of these operons is controlled by distinct regulatory systems that 
respond to different metabolic signals. Thus, gaining a better appreciation for the 
metabolic cues sensed by the CidR and LytSR regulatory systems, as well as the 
metabolic differences between these tower types, will be essential for understanding the 
basis for the expression differences observed.  
 Given the proposed functions of the cid and lrg operons, we next wanted to 
examine the correlation between expression of these genes in a biofilm, and the death 
and lysis that occurs in these structures. As shown in Figure 4-12, analyses of the cid 
reporter construct revealed that the GFP signal produced by the cid::gfp strain 
overlapped with the PI staining, which was previously shown to be particularly evident in 
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these structures (100). However, it is clear that this overlap is incomplete as evidenced 
by the observation that the high-level expression observed in the smaller towers was not 
associated with PI staining (Figure 4-12, middle row panels). In contrast, fluorescence 
produced by the lrg::gfp strain correlated much better with the PI-stained structures 
(Figure 4-12, bottom row panels) exhibiting homogeneous fluorescence throughout the 
large towers and no fluorescence in the small towers. Since the cidA and lrgA gene 
products are proposed effectors of cell death and lysis, one might predict that the 
disruption of these genes would affect the death and/or lysis observed by PI staining. 
However, similar experiments using cid and lrg mutants harboring the cid and lrg GFP 
reporter constructs revealed no obvious effect on the pattern of cell death and lysis (as 
indicated by PI staining; data not shown), suggesting that the roles of these genes are 
not readily detectable under these conditions. One scenario is that the Cid and Lrg 
proteins encoded by these operons simply potentiate cell death and under biofilm 
conditions makes this process more efficient. In fact, holin proteins function much like 
this as they are expressed and inserted in the membrane in an inactive form and can be 
induced by lethal agents that dissipate the membrane potential (244). Similarly, altered 
expression of members of the Bcl-2 family of proteins, critical in the control of apoptosis, 
does not directly affect cell viability but instead, potentiates cell death or survival 
depending on the relative levels of death effectors or inhibitors that are present in the 
cell (245). Another hypothesis is that this BioFlux1000 system uses two-dimensional 
image acquisition software and microfluidic flow-cell conditions. These capabilities may 
not have the sensitivity to evaluate slight changes in biofilm morphology like previously 
described flow-cell biofilms that have taken advantage of confocal scanning laser 
microscopy to render three-dimensional images and quantify subtle changes using 
sophisticated biofilm quantification software called COMSTAT (246).  
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 Given the apparent fundamental differences in gene expression and physical 
properties of large versus small towers, a better understanding of the relative 
physiological differences between these tower types should provide valuable information 
about the control of cell death during biofilm development. Furthermore, insight into the 
potential functional differences that are associated with spatially and temporally 
regulated genes within the biofilm, as has been observed in Bacillus subtilis (247), could 
be particularly enlightening. Thus, current studies using Bioflux technology are aimed at 
using fluorescent metabolic probes that will allow us to correlate the temporal and spatial 
aspects of cid and lrg expression with differential physiological states within biofilm 
microenvironments, providing more mechanistic and functional insights into the 
heterogeneous control of cell death and lysis observed within a developing biofilm.  
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CHAPTER V: 
CONCLUSIONS AND FUTURE DIRECTIONS 
  
 In this dissertation, we have developed a model of S. aureus biofilm development 
using the BioFlux1000 microfluidic device that is described in five sequential stages: 1. 
attachment, 2. multiplication, 3. exodus, 4. tower maturation, and 5. dispersal (Figure 5-
1). More specifically, S. aureus biofilms cells first attach to the bottom of the glass 
bottom plates (Figure 5-1A). Then, as fresh media is perfused across attached cells, the 
biofilm develops into a confluent ‘mat’ of cells (multiplication) (Figure 5-1B). Upon 
reaching confluency, a period of mass exodus of cells occurs in which a subpopulation 
of cells is released from the biofilm (Figure 5-1C) allowing the formation of distinct three-
dimensional structures. These structures, designated as towers, form from distinct foci of 
cells that rapidly divide to form robust aggregations (Figure 5-1D). It is at this point that 
portions of the tower begin to disperse to start the process again (Figure 5-1E).  
 
Attachment and Multiplication 
 During the attachment and multiplication stages, we discovered under these flow-
cell conditions that this phase appears to rely primarily on proteins, rather than eDNA or 
PIA, given that the initial stages of development are susceptible to proteinase K 
treatment. In addition, we also discovered that proteins such as AtlA and δ-toxin 
potentially interact with the glass surface of the BioFlux plate presumably through charge 
interactions. Additionally, by screening the Nebraska Transposon Mutant Library, we 
found that most LPXTG-motif containing proteins and MSCRAMM proteins appeared to 
not have a major role during the initial stages. However, it cannot be ruled out  
113 
 
 
 
 
 
 
Figure 5-1 Working model of Staphylococcus aureus biofilm development in 
BioFlux1000 
 
S. aureus biofilm development using the BioFlux1000 microfluidic device is described in 
five stages: 1. attachment, 2. multiplication, 3. exodus, 4. tower maturation, and 5. 
dispersal. (Figure 5-1A; Attachment) S. aureus biofilms cells first attach to the bottom of 
the glass bottom plates. (Figure 5-1B; Multiplication) As fresh media is perfused across 
attached cells, the biofilm develops into a confluent ‘mat’ of cells. (Figure 5-1C; Exodus) 
Upon reaching confluency, a period of mass exodus of cells occurs in which a 
subpopulation of cells is released from the biofilm allowing the formation of distinct three-
dimensional structures. (Figure 5-1D; Tower Maturation) These structures, designated 
as towers, form from distinct foci of cells that rapidly divide to form robust aggregations. 
(Figure 5-1E; Dispersal) It is at this point that portions of the tower begin to disperse to 
start the process again. 
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that there may be involvement of more than one of these proteins, and that disruption of 
a single gene encoding one of these proteins may not cause a large enough defect to 
see any changes in biofilm development.  
 To continue to determine the functions that the AtlA protein has during biofilm 
development, a more detailed approach must be taken. Given that AtlA is the major 
autolysin of S. aureus, we cannot rule out that the fact that a defect in this protein will 
generate cells with a defective cell wall that could lead to drastic effects on the 
placement of extracellular proteins of the cell surface or in a developing biofilm. 
Therefore, further genetic approaches using point mutations aimed at dissecting the 
enzymatic activity in conjunction with extracellular protein profiling of these may provide 
results that can determine whether or not a defective AtlA is disrupting proper 
extracellular protein placement. In addition to processing the cell wall of S. aureus, the 
glucosaminidase domain of AtlA has also been shown to bind DNA suggesting that there 
may be a potential eDNA-protein interaction that is occurring within the biofilm matrix. 
Hence, using DNA-specific stains and/or antibodies in combination with genetic 
mutations of the DNA-binding domain may aid in determining the effects that AtlA has a 
possible eDNA-binding protein. Lastly, AtlA also serves as a mediator of lysis and eDNA 
release during biofilm development. In order to better understand this process, genetic 
mutations disrupting functional enzymatic activity may provide immense information on 
how this process is occurring. 
 The PSMs including δ-toxin are well-characterized in their functions in S. aureus 
biofilm development. Nonetheless, to determine if there is a direct function of δ-toxin 
under our biofilm conditions, either a δ-toxin mutant must be obtained or constructed and 
then evaluated for biofilm development in the BioFlux1000. One complicating issue with 
studying the δ-toxin is that the hld gene resides within the RNAIII-transcript (116). 
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Therefore, a mutant with a generated translational termination site that does not interfere 
with the RNAIII transcript would need to be generated. Based, on previous reports 
evaluating the role of δ-toxin and the other PSMS in biofilm development (117), we 
hypothesize that we would see robust biofilm growth after the exodus stage in a δ-toxin 
mutant when compared to wild-type. 
 In addition to the large contribution of extracellular proteins to the biofilm ECM 
during the attachment and multiplication stages, there also appears to be a contribution 
of eDNA, given that a defective nuclease causes abrogation of the exodus event. As 
discussed before, there may be eDNA-protein interactions that act as scaffold for the 
biofilm matrix. One particularly interesting group of eDNA-binding proteins are the 
nucleoid- associated proteins ( NAPs) which have been shown to have a function in the 
ECM of staphylococcal biofilms (107). To determine if NAPs indeed have function in 
biofilm scaffolding, the first thought would be to construct a mutation in the gene 
encoding the NAP protein. However, this is impossible because the protein is essential 
to S. aureus survival (193). An additional factor that may complicate studying this protein 
is that disruption of a gene that is important for chromosomal condensation may have 
drastic effects on global regulation within the cell and not solely on eDNA-protein 
interactions in the biofilm ECM. Thus, non-mutational microscopy approaches utilizing 
eDNA specific stains and/or antibodies in conjunction with NAP-specific antibodies are 
currently being conducted to determine if there are NAP-eDNA interactions contributing 
to the ECM within the multiplication stage.    
 One major complicating issue that often causes disagreement between 
investigators on which molecular determinants are important for biofilm development is 
that researchers use varying degrees of biofilm conditions including different types of 
media, shear stresses, and plasma coating. Therefore, to continue to determine the 
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potential functions that some of these previously described proteins have in biofilm 
development, we must test our mutants in several experimental conditions. One simple 
experimental condition to change would be to coat the microfluidic channels of the 
BioFlux with host substrates that are found in human plasma rather than allowing the 
cells to adhere directly to the glass bottom of the BioFlux plate. This has already been 
performed in a recent study where the S. aureus cells were allowed to adhere to human 
plasma. Under these conditions, the authors discovered that saeRS mutants actually 
generated less overall biofilm development when compared to their respective UAMS-1 
and JE2 wild-types even under similar shear stress conditions (42). This is directly 
opposing to what was discovered in our studies in this dissertation. Thus, the mutants 
used throughout in this dissertation must also be examined under various experimental 
biofilm conditions to determine if their functions are dependent on other biological 
conditions. 
 
Exodus 
 The exodus stage is an early biofilm dispersal stages that precedes the 
maturation of tower structures. It was first described in these studies and was named 
this to delineate between the Agr-mediated dispersal events that have been described 
vigorously in the literature. While exodus was first described in these studies, in the past, 
there have been several reports describing that S. aureus produces nucleases that 
modulate biofilm development by degrading eDNA within the ECM. However, none of 
these previous studies provided as much detail into the timing and regulation. As 
described in these studies, exodus is clearly mediated by the degradation of eDNA by 
the secreted nuclease, and is tightly regulated by the multi-component Sae system. 
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Indeed, the Sae system regulates the exodus process so tightly that only a 
subpopulation of cells expresses nuclease. In further support of this, the subpopulation 
of cells becomes highly dysregulated when genes within the sae operon begin to be 
mutated.  
 One question is why does disruption of the gene encoding the SaeP protein 
cause every cell within the biofilm to express nuclease and other Sae-regulated factors? 
As previously discussed, this may be because deletion of SaeP cannot form a complex 
with SaeQ to activate the phosphatase activity of SaeS causing the cells to lack a 
mediator of self-control in SaeS phosphorylation, and uncontrolled transcription levels of 
Sae-regulated factors. Another thought is that the SaeP protein located on the surface of 
the subpopulation of cells is binding eDNA within the ECM, and thus, unable to interact 
with SaeQ to repress transcription of Sae-regulated genes. This makes sense 
considering when saeP is deleted all of the cells in the biofilm transcribe the gene 
encoding nuclease and staphylocoagulase. From these data, it’s obvious that the next 
steps are to determine the eDNA-binding sites in SaeP, and then genetically mutate 
these sites and determine the effect on nuclease expression in both biofilm and 
planktonic studies. Considering that there are recent examples of different bacterial 
species including B. subtilis, P. aeruginosa, and Caulobacter crescentus (204) that 
sense the constituents of the biofilm matrix and regulate specific genetic programs within 
the biofilm cells, S. aureus may also undergo a similar process to utilize the Sae system 
to sense eDNA concentrations with ECM to trigger a dispersal mechanism.   
 Another obvious question that can easily be addressed is how many different 
Sae-regulated genes demonstrate similar expression patterns within a biofilm when 
compared to nuclease? This can addressed by constructing additional dual fluorescent 
promoter fusion constructs of Sae-controlled genes such as hla, hlb, fnbA, efb, P1sae, 
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sbi, fib and cap, and then moving these constructs into the sae mutant backgrounds and 
evaluating the effects that they have on expression within a developing biofilm. Indeed, 
these constructs are currently being generated in the laboratory. In combination with this 
method, our laboratory is also attempting to remove the biofilms from the microfluidic 
channels by using enzymatic destruction of the biofilm matrix, and  then conducting 
fluorescence-activated cell sorting flow cytometry to not only count the number of 
fluorescently positive cells, but to also sort the cells for further transcriptomic and 
proteomic analyses. Considering that there are two target classes of Sae regulation that 
rely on the phosphorylation of SaeS, we hypothesize that not all of the Sae-controlled 
genes will be demonstrate stochastic expression in a subpopulation of cells like 
nuclease. However, we predict that genes in the same Sae target class will demonstrate 
similar expression patterns.     
 
Tower Maturation 
 The studies presented here provide further confirmation that biofilms are 
multicellular communities that contain both physiologic and metabolic heterogeneity. 
Perhaps, one of the most obvious examples of heterogeneity in S. aureus biofilm 
development is the tower maturation stage. It is in this stage where two distinct tower 
types are formed. First, following the exodus stage, there are the large tower types that 
rapidly divide from a distinct to foci to form large robust structures. Within these 
developing towers, we observed differential regulation of the cell death operons, cidABC 
and lrgAB. More specifically, the large towers demonstrated constitutive expression of 
the lrgAB operon throughout the entire time of development. Conversely, cidABC 
expression was not observed until the tower reached a particular robust size, at which 
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point, expression was seen within the most internal regions of the tower. We 
hypothesized that this internal cid expression was due to hypoxic conditions with the 
tower structure. Thus, we tested an ldh1 reporter fusion, known to be expressed under 
hypoxic conditions, to determine similar expression patterns. This suggested an intimate 
connection with the metabolic status of the cell within the towers. In addition to the large 
tower types, there were was also the emergence of small tower types that developed 
from distinct foci of cells also. However, the small towers appeared to be less cohesive 
and grew more slowly when compared to their larger counterparts. In addition, these 
smaller tower types constitutively expressed cid, but interestingly, did not express lrg, 
suggesting another form of differential regulation. Strikingly, cell death and eDNA were 
only observed in the large tower types. 
 Given the intimate relationship that these operons have shown with the metabolic 
status of the cell, in particular overflow metabolism, we hypothesize that these 
expression differences are in response to metabolic status in the cells. In support of this 
when we evaluated mutations Pta-AckA pathway, we saw increased cid expression as 
well as the increased prevalence of small towers. Expanding upon these data, a recent 
study from our laboratory also demonstrated a direct relationship with acid stress and S. 
aureus biofilm formation. Under the BioFlux biofilm conditions, there were no 
distinguishable differences in biofilm morphology between mutations in either the cid or 
lrg operons. However, under other flow cell conditions there was a clear connection in 
tower formation and regulation of cell death genes, cidC and alsSD, both of which are 
regulated by the CidR regulon, (103). In addition to this, another study from the 
laboratory showed that genetic mutations effecting the signal transduction of the LytSR 
two-component, the primary regulator of lrgAB, developed unique biofilm characteristics 
(101). 
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 Considering the close relationship with cid and lrg operons and the effects seen 
on S. aureus biofilm development, one would think that an obvious way to evaluate the 
effects of metabolism on these cell death operons would be to delete genes encoding 
important enzymes in key metabolic pathways. However, this produces a couple of 
caveats when looking at biofilm formation. One, deletion of metabolic enzymes often has 
significant grown defects, making it extremely difficult to compare biofilm morphologies 
of mutants to wild-type. Two, S. aureus is very adaptable organism and has several 
ways to obtain and utilize carbon to ensure survival; therefore, mutating one metabolic 
enzyme may cause a shift in carbon to another pathway making it difficult to determine 
differences in biofilm formation. Last, some metabolic enzymes are essential to the 
growth of the organism and cannot be disrupted. To circumvent these caveats, we are 
currently designing fluorescent promoter reporter fusions to key enzymes involved in 
carbon metabolism. Although these may not provide a direct indication of activity of 
these enzymes, they can provide insight in to where these enzymes are being 
expressed and whether or not they correlate with the expression of cid and lrg during 
biofilm formation. Additionally, if cells expressing these reporter fusions linked to 
metabolic enzymes can be sorted using flow cytometry, transcriptomic and proteomic 
analyses may be performed to provide further insight to protein production and activity. 
In conjunction with fluorescent reporters, the use of stains or dyes that indicate the 
metabolic state of the cell are also currently being considered to aid in determining the 
metabolism within a developing biofilm. 
 Another interesting question is why does S. aureus want to form towers? 
Typically, we think of thicker biofilms as being more resistant to antibiotics and other 
antimicrobials. While this is usually the case, there is some data in other bacterial 
species like Pseudomonas species suggesting that formation of tower-like structures in 
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aid in resistance to antimicrobials (211). Hence, we are also currently designing 
experiments to test the resistance of cells within the towers to antibiotics or other 
antimicrobials. 
 In conclusion, the standardization of the BioFlux1000 microfluidic flow-cell 
system to cultivate S. aureus biofilms has provided unprecedented views of the stages 
of biofilm development in real-time manner. The results of these studies also further 
demonstrate the unique multicellular and heterogeneity characteristics of S. aureus 
biofilms. Clearly, there is much more to be learned about the regulation of the Sae-
controlled nuclease-mediated exodus event and the signal that triggers nuclease 
expression as well as the metabolic heterogeneity that determines the expression of the 
cidABC and lrgAB operons. Still, these studies have laid the fundamental groundwork for 
further studies to expand upon these fascinating processes in hope of a better 
understanding S. aureus biofilm development to create novel anti-biofilm therapeutic 
strategies.    
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